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Abstract
The development of biocompatible polymers using thiol-acrylate Michael addition
reactions between not only acrylates and thiols but also between amines and acrylates
were demonstrated. The synthesis of an in situ tertiary amine catalyst initiates the
propagation steps of the polymerization process by subsequently reacting with
trimethylolpropane tris (3-mercaptopropionate) (TMPTMP). A few notable
characteristics of this reaction are tunable gel times, the capability of reaching high
polymer conversion and suitable mechanical strength. With addition of hydroxyapatite to
the polymeric phase and foaming, a porous bone composite was produced. Further
osteogenisis and in vivo work using the PETA-co-TMPTMP (HA) composite material
was analyzed. The PETA-co-TMPTMP-co-TMTMP with 20%HA showed an increase in
osteogenic potential higher than the FDA approved PCL over the 21-day study. The rats
did not exhibit any severe systemic responses from the polymer implant, and an
increase in bone growth was observed for the rats containing PETA-co-TMPTMP (HA)
samples compared to the rat containing no polymer. An antimicrobial study on the
PETA-co-TMPTMP polymer was also performed by adding silver nanoparticles to the
PETA-co-TMPTMP polymer to provide an antimicrobial component to the already wellestablished bone replacement polymer. By coating the polymer in a silver containing
solution and adding 20%excess thiol to the polymer, it was effective at reducing
common bacteria.
While the application of the PETA-co-TMPTMP polymer has proven to be
effective for osteogenic bone scaffolds, the reason a material without cell adhesive
moieties supported stem cell growth remained elusive. The next study used

vii

polyethylene glycol diacrylate (PEGDA) and trimethylolpropane ethoxylated triacrylate
(TMPeTA) to understand the relationship between thiol-acrylate polymers and cell
adhesion. Wettability, modulus, and degradation stability were all tested, and it was
observed that these properties play a role in the adhesion to these materials. As per
live/dead staining, cell morphology changed to spindle shape on the lower molecular
weight, 692 TMPeTA samples whereas the 912 TMPeTA’s cell morphology remained
the same. Cell adhesion on the TMPeTA(692) polymer versus the TMPeTA(912) is
likely due to the 692 polymer yielding an overall tighter crosslinked network, and it’s
contact angle falling in the range for not being too hydrophilic/hydrophobic.
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Chapter 1. Introduction
1.1 Thiol-Ene Chemistry
Thiol-ene chemistry, revived by Professor Charles Hoyle, takes place by the
reaction between carbon-carbon double bonds and thiol functional groups(Scheme 11).1,2 Two different reaction pathways occur for thiol-ene polymerizations and are noted
by anti-Markovnikov radical addition and Michael addition base/nucleophile catalyzed
mechanisms.3 Thiol-ene chemistry using photo or thermal initiators (Scheme 1-2) has
been studied extensively and used for many applications.4-5 The general radical thiolene polymerization reaction produces thiyl radicals, which adds to an ene functional
group. The hydrogen from another thiol can be abstracted in the second reaction to
produce another thiol radical.

Scheme 1-1. General thiol-ene mechanism
The two radicals that were previously produced in the two propagation steps can
react together to terminate the growing chains. A relatively uniform crosslinking network
that usually proceeds rapidly at standard conditions without oxygen inhibition is
produced. Oxygen usually inhibits radically initiated polymerization reactions, especially
in thin films due to the rapid diffusion of oxygen, by forming peroxy radicals with the
initiator or propagating species. The growing radical chain reacts with oxygen forming
ROO• radicals that is not as reactive thus inhibiting the polymerization. On the contrary,
with a thiol present, this reaction is significantly minimized by the peroxy radical reacting
with the thiol by abstracting a hydrogen from it thus forming a stable species and
eliminating the radical species.6
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Scheme 1-2 Free-radical thiol-acrylate photopolymerization showing two pathways:
acrylate homopolymerization and thiol-acrylate copolymerization.
A thiol-ene reaction using amine-catalyzed Michael addition click chemistry
allows for the production of polymeric materials that have the ability to be synthesized
efficiently at room temperature.7 A Michael addition can occur between thiol containing
molecules and electron–deficient molecules such as vinyl esters, acrylates,
methacrylates, maleimides, and unsaturated α, β ketones.8 Thiol-acrylate Michael
addition chemistry, which will be the focus of this dissertation, is a subset of thiol-ene
chemistry in which the ene species is an acrylate. Two different Michael addition thiolacrylate anionic routes can proceed via a nucleophile-initiated mechanism or a basecatalyzed mechanism. For the nucleophile-mediated mechanism, the nucleophile
attacks the β-carbon on the alkene initiating the reaction forming a strong enolate base
that abstracts hydrogen from an acidic component present in the reaction as shown in
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scheme 1-3. In the case for the nucleophile-mediated reaction, the acidic component is
the thiol. This deprotonated thiol reacts with the electron deficient acrylate forming an
enolate, which does a hydrogen transfer with another thiol thus repeating the chain
propagation step. As discussed by Chan et al., if the nucleophile used for the
nucleophile-initiated reaction also acts as a base such as amines, it may lead to a mix
of mechanisms since the base can both deprotonate the thiol and add onto the double
bond.8

Scheme 1-3. Nucleophile-initiated thiol-acrylate mechanism using a secondary
amine.
The mechanism of the base-catalyzed reaction has been thoroughly investigated
and is shown in Scheme 1-4.9 The base deprotonates a thiol forming a thiyl species,
which forms an anionic species with the electron deficient enes that start a chain
propagation process.3,10 One difference between the Michael addition reaction and a
free-radical thiol-ene polymerization is the absence of the self-termination step.
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Termination most commonly occurs by two active radical species reacting with one
another instead of the monomer or by oxygen inhibition.

Scheme 1.4 Base-catalyzed thiol-acrylate reaction mechanism
Biomedical materials using photoinitiators such as benzoyl peroxide that
generate radicals to initiate the reaction, have shown cell necrosis and aptosis.11
Despite the harsh effects of radicals, PEG-based materials synthesized using thiolacrylate photopolymerization chemistry have been studied extensively in many
biocompatible applications such as tissue replacement due to PEG’s hydrophilicity and
similarities to the extracellular matrix found within the body.12,13 As previously
discussed, the thiol present in the PEG-based photopolymerization helps to minimize
the radical inhibition.
A tertiary amine catalyst, synthesized by reacting a trifunctional acrylate with a
secondary amine, acts as a base to deprotonate the trifunctional thiol producing a thiyl
anion. This thiyl anion begins the two propagation reactions. The tertiary amine catalyst
is covalently bound to the acrylate monomer, prohibiting any leaching of hazardous
byproducts. Another advantage of this reaction is that no light or heating element is
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needed to drive the polymerization. This reaction, therefore, is more attractive for in situ
polymerization in a critical sized bone defect than free-radical-based methods. With the
advantage of the in situ amine catalyst Michael addition reactions, the biomedical
application of thiol-acrylate Michael addition polymerization reactions was studied
thoroughly.14,9
1.2 Tissue Engineering
Tissue engineering uses numerous material and cell techniques to repair or
replace damaged tissues such as bone, cartilage, skin, ligaments, and the heart.15 Bone
regeneration has been a well-studied area of tissue engineering often encompassing
many different approaches. The current technology for bone replacement uses
autografts that include the patient’s bone and allografts that are harvested from a donor.
Synthetic scaffolds offer an alternative to the traditional grafts, but it remains a
challenge for synthetic scaffolds to meet all of the requirements needed for tissue
engineering to be a successful alternative. For a scaffold to meet the requirements for
bone tissue engineering, properties of a scaffold must include biocompatibility,
biodegradability, mechanical integrity, and porosity.16 The scaffold must be
biocompatible and support cell adhesion. Biodegradability of a material should occur at
the same rate in which the bone tissue is being regenerated while not releasing any
harmful degradation products. Mechanical integrity provides enough structural support
to the void space to allow for movement. Porosity allows for the transport of minerals
and the elimination of wastes while providing an interconnected network of blood
vessels and tissue to form.17
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Natural polymers structures such as chitosan, collagen, and chitin have been
demonstrated as scaffolds for bone replacement but tend to be inconsistent depending
on the environmental sources obtained of each. Despite the drawbacks, these polymers
are abundant and can easily be processed into devices by casting, extrusion, molding
or coating.
Additionally several other polymer systems such as poly(ethylene glycol)
(PEG),18,19 and polyurethane (PUV),20 have been shown to support hASC proliferation
and differentiation. The clear advantage of synthetic polymers is that they are highly
pure, readily reproducible and have flexible mechanical, chemical and biological
properties allowing them to be tailored to suit specific functions. A significant
disadvantage of using synthetic polymers is that some, such as PLGA and PLLA,
degrade into products, often acids that can perturb the scaffold microenvironment
leading to cell dysfunction, death and potential rejection.21 Families of these polymers
have had their structures tuned to enhance certain properties needed for bone
replacement. PLLA and PLGA are structurally similar with the main difference occurring
in PLLA with the pendent methyl group. The methyl group causes the molecule to have
chirality opening up the possibility of different isomers depending on the application.
PLGA’s main disadvantage is the rapid degradation in vivo due to the extent of
crystallinity contained throughout the polymer. Another polymer of interest, PCL is
poorly water-soluble with a melting temperature of 58 to 63 °C.22 Similar to PLLA and
PLGA, the degradation of PCL occurs by bulk or surface hydrolysis of ester linkages
resulting in a byproduct of caproic acid.18 PCL degrades slowly in physiological
conditions and can persist in vivo for up to 2 years.22 At high concentrations of these
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degradation products, local tissue acidity may increase, resulting in adverse responses
such as inflammation or fibrous encapsulation.22
Common bone replacement materials are nanocomposites that contain an
inorganic phase and a polymeric organic phase. The inorganic phase is usually a
ceramic material that should mimic, as closely as possible, the natural bone architecture
to ensure cell attachment and migration within the porous materials. Additionally,
ceramics should be absorbed overtime or integrated with the surrounding tissue and
eventually replaced by new or existing host tissue.22 Bioceramics used in current hASC
osteogenic studies include custom-made akermanite, β-TCP scaffolds, HA/β-TCP
composites23, and bioactive glass; commercially available scaffolds made of β-TCP
(Synphare® and ChronOS®)24, HA (Engipore®), HA/β-TCP composites (CopiOSTM Bone
Void Filler)25, Titanium (Trabecular Titanium®)26; and polymeric composites made of βTCP and HA. Hydroxyapatite [Ca5(PO4)3(OH)] is the most common ceramic used since
it’s commercially available and cost-efficient. It is an inorganic crystalized mineral found
in teeth and bones with porosity and percent mineralization varying among bone types
that enhances the osteogenic capability of polymeric materials, thus aiding in bone
formation in vivo.27
One property that is important to the formation of blood vessels, vital nutrients,
and mineral support of a bone scaffold is its porosity.28,29 Fabrication methods of the
scaffold affect the porosity and thus must be chosen to maintain the structure of the
scaffolds. Porosity can be achieved within a polymer scaffold by thermal induced phase
separation precipitation, which relies on the thermodynamic instabilities of two polymer
phases. Particulate leaching only dissolves the added precipitate via evaporation of the
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solvent that is added previously to the scaffold.30 Thus, pores appear where the solvent
dissolved the precipitate granules. Crosslinked thiol-acrylate polymers are often
thermoset in nature, thus the use of solvents is not applicable. A fabrication method not
using solvents is termed gas-foaming that involves a blowing agent (i.e. nitrous oxide)
that can be applied to a nanocomposite material in a pressurized foaming apparatus.
The expelled polymer/ceramic matrix has the ability to directly conform to a bone void
by tuning the polymer gelation time without the need for pre-sculpting before placement
into the defect.
However, the progression and expansion of synthetic composite materials used
for tissue engineering caused a greater need for materials to contain an integrated
antibacterial component. Many bacterial infections are associated with orthopedic
surgeries that use implants, thus the prevention of acquiring such infections without
having antimicrobial resistance is vital to the field of tissue engineering. Saravanan et. al
demonstrated inoculation of E. coli and S. aureus by incorporating silver nanoparticles
into a composite synthesized using chitosan and hydroxyapatite.31 The mechanism to
which silver ions kills bacterial cells remains elusive, but some theories note the
attachment and penetration of the silver ions to the cell wall of the bacteria, which
disrupts the enzyme activity.32
1.2.1 Cell Seeding
Cell seeding and cell encapsulation are two thoroughly researched
methodologies to transport cells into the body thus decreasing the time needed for
tissue regeneration. Cell seeding, the placement of cells onto the surface of a synthetic
scaffold, is often used as an in vitro method to determine how the material will support
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the growth of tissues in vivo on the surface. The adhesion of stem cells to a polymeric
surface is a complicated process involving integrins and other ECM proteins. The
mechanical strength and crosslinking density play a role by withstanding force that the
cell exerts as it spreads across the polymer’s surface. The wettability of a polymer
determined by contact angle measurements is an important property where the contact
angle should be in a moderate hydrophilicity range to support cell adhesion.
Extensive research has been performed on the functionalization or incorporation
of cell adhesive moieties into synthetic scaffolds to support cell adhesion, but not many
inert polymers without RGD or collagen peptides have been studied.33 The incorporation
of RGD into the polymerization process is expensive and time consuming with extensive
purification needed. Rydholm et al. used unreacted thiol molecules that are usually
leftover after thiol-acrylate photopolymerizations due to the homopolymerization of
acrylates to attach RGD to acrylated PEG(3400).34 Khire et. al showed how a thiol SAM
gradient was used to obtain an osteoblast gradient via a Michael addition using
RGDS.35
1.2.2 Cell Encapsulation
Cell encapsulation within a 3D matrix offers a different perspective to the 2D
seeding monolayer methods by allowing cells to migrate throughout a scaffold and
intramolecularly communicate with each other. The scaffold should provide structural
support while still providing a means for transporting and binding the encapsulated cells
together for in vivo purposes. With the entire 3D scaffold being comprised of cells, the
size constraints of cell spreading often exhibited in cell seeding are not an issue. The
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surrounding tissue in vivo gives off biological signals that direct tissue growth to the
cells throughout the entire 3 dimensional structure.
Many different hydrogels have been used for the cell encapsulation.36,37 Alginate
is a polysaccharide of (1-4)-linked β-D-mannuronic acid (M) and α-L-gulutonic acid (G)
that varies in sequence and number depending on the sources and molecular weight of
the co-polymer. It forms a gel immediately by contact with a solution of CaCl2. The
positively charged calcium ions complexes with the negatively charged carboxylic acid
component of the repeating mannuronic and gulutonic groups within alginate forming a
hydrogel.
Cell-laden alginate beads have shown success in the encapsulation and viability
of stem cells. Siti-Ismail et al. kept cells viable for up to 260 days in alginate-Ca beads in
cell media without any external alteration.38 While alginate beads act as a nontoxic
vehicle for transplanting cells into the body, they lack the ability to adhere cells to its
surface; therefore there have been a number of articles published on mixing alginate
and gelatin to the alginate mixture before cells are added to it.39 Rui et al. showed an
increase in cell proliferation and adipogenic differentiation for the gelatin/alginate beads
compared to the alginate beads.40 Mixing collagen with alginate has also been
successful in increasing proliferation.41
Other common hydrogels used for the immobilization of cells are agarose and
gelatin. Agarose consists of galactose and anhydrogalactopyranose that forms a gel
when cooled due to its upper critical solution temperature (UCST). The
monosaccharides are water-soluble with each other and are in a random coil formation
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above that temperature. Below the UCST, the structure changes to a double helix
forming a gel, and the H-bonding between the water and the galactose stabilize it.42
Research has also been done in the Mikos research group where Wang et al.
used gelatin as a leaching porogen contained within an oligo(poly(ethylene glycol))
fumarate to form a macroporous hydrogel that successfully encapsulated stem cells
with viability of 16 days.43 Hoffman et al. demonstrated how stem cells could be
transplanted by encapsulating cells within a PEG based hydrogel. The degradation of
the hydrogel was tuned to spatially and temporally control the migration of stem cells
throughout the gel by increasing the mesh size.44
Kristi Anseth and colleagues have shown in numerous papers the impact of
spatial and temporal control throughout the scaffold has on the regeneration process.45
Contrary to the previous work described, polysaccharides were not used for the
encapsulation process. Instead, tethering functional groups to a hydrogel was
demonstrated by functionalizing PEG hydrogels with phosphates, Benoit et.al was able
to tailor encapsulated stem cells to undergo osteogenisis differentiation by this
method.46
This dissertation entails an in depth study of thiol-acrylate polymers synthesized
via a base-catalyzed or nucleophile-initiated mechanism. PETA-co-TMPTMP is
demonstrated in the second chapter as a highly crosslinked thiol-acrylate network that
could be used a biomaterial. The PETA polymer will be mixed with hydroxyapatitie and
characterized by performing mechanical and cyto-toxicity studies. PETA-co-TMPTMP
was further studied in chapter three for its osteogenic capability, antimicrobial
application, and in vivo study using a live animal spinal fusion model. The fourth chapter
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characterizes different PEGDA(700) based polymers and cell behavior on them. The
chapter then goes into a more detailed study focusing on two different Mn polymers with
varying amine concentrations and the properties needed for the adhesion or nonadhesion of stem cells. Encapsulation of hASCs using alginate and agarose within a
polymer matrix including PEGDA(700) and TMPeTA(692 & 912) polymers is also
described using live/dead staining.
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Chapter 2. PETA-co-TMPTMP(HA) Composites for Bone Replacement
2.1 Chapter Summary
Bone tissue engineering approaches using polymer/ceramic composites show
promise as effective biocompatible, absorbable, and osteoinductive materials. A novel
class of in situ polymerizing thiol-acrylate based copolymers synthesized via an aminecatalyzed Michael addition was studied for its potential to be used in bone defect repair.
Both pentaerythritol triacrylate-co-trimethylolpropane tris(3-mercaptopropionate) (PETAco-TMPTMP) and PETA-co-TMPTMP with hydroxyapatite (HA) composites were
fabricated in solid cast and foamed forms. These materials were characterized
chemically and mechanically followed by an in vitro evaluation of the biocompatibility
and chemical stability in conjunction with human adipose-derived mesenchymal
pluripotent stem cells (hASC). The solid PETA-co-TMPTMP with and without HA
exhibited compressive strength in the range of 7–20 MPa, while the cytotoxicity and
biocompatibility results demonstrate higher metabolic activity of hASC on PETA-coTMPTMP than on a PCL control. Scanning electron microscope imaging of hASC show
expected spindle shaped morphology when adhered to copolymer. Micro-CT analysis
indicates open cell interconnected pores. Foamed PETA-co-TMPTMP HA composite
shows promise as an alternative to FDA-approved biopolymers for bone tissue
engineering applications.
2.2 Introduction
Bone tissue engineering shows promise as an alternative strategy to current
surgical techniques to replace or restore the function of traumatized, damaged, or lost
bone.47,48 Over the past several decades, bone grafts have advanced as standard
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treatment to augment or accelerate bone regeneration.48 Autogenous and allogeneic
bone grafts do not provide a clinically convenient method for conformal filling of a critical
sized bone defect compared to a proposed injectable biomaterial providing mechanical
support and biological cues to support bone regrowth.
To date, a clear trend towards the use of composite scaffolds as an alternative to
allogeneic or autogenic bone can be observed in many of the current models.49-52
Native bone is composed of naturally occurring hydroxyapatite (HA) crystals distributed
within an organic matrix, with porosity and percent mineralization varying among bone
types.48 Synthetic HA has been widely used in bone scaffold fabrication because it
possesses osteogenic properties.53,54 While several of these studies involved the use of
extracellular matrix or other naturally occurring compounds such as collagen,
decellularized bone or chitosan, synthetic polymers can be highly pure, readily
reproducible and have adaptable mechanical, chemical, and biological properties to suit
specific clinical applications. Much of the research utilizing synthetic polymers in
hASCs-combined tissue engineering has been focused on hybrid cell/scaffold
constructs using degradable polyester polymers such as poly(lactide-co-glycolide)
(PLGA), poly(L-lactide) (PLLA), and poly-ε-caprolactone (PCL).
Thiol-ene chemistry possesses many advantageous properties for tissue
engineering applications.48-51 Specifically; thiol-acrylate chemistry has already been
used in biomedical applications, but has only been explored in photolytically
polymerized systems.34,55,56 Thiol-acrylate polymers synthesized via an amine-catalyzed
Michael addition reaction have not been explored for biomedical applications. Scheme
2-1 displays how the general reaction proceeds by the formation
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Scheme 2-1. In situ tertiary amine catalyzed anionic step growth polymerization
mechanism.
of a catalyst/comonomer molecule through the Michael addition of the secondary amine
(diethylamine) across the double bond found in acrylate monomers. These activated
acrylates were then individually mixed with a thiol comonomer (trimethylolpropane
tris(3-mercaptopropianate)). This in situ tertiary amine catalyzed Michael addition
proceeds via a chain “process” due to the sequential chain transfer step after each
addition. The Michael addition reaction causes the polymerization to follow the rules and
attributes of a step-growth mechanism in terms of molecular weight and physical
properties.
In this study, the synthesis and characterization of a novel class of thiol-acrylate
copolymers has been reported.57 The tunable gel times and mechanical properties were
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determined. A series of biocompatibility tests indicate this new synthetic polymer is
capable of supporting human adipose derived stromal cell culture. Furthermore, SEM
and micro-CT studies illustrate the morphology of solid and foamed PETA-co-TMPTMP
HA composites. These materials are a potentially transformative class of novel
biomaterials with the application for in situ conformal polymerization at the site of
trauma.
2.3 Methods and Materials
2.3.1 Chemicals
All chemicals were used as received. Trimethylolpropane triacrylate (TMPTA),
poly(ethylene glycol) diacrylate (PEGDA) (Mn 700), poly(ethylene glycol) diacrylate
(PEGDA) (Mn 575), poly-ε-caprolactone (PCL), trimethylolpropane ethoxylate triacrylate
(TMPeTA) (Mn 912), trimethylolpropane ethoxylate triacrylate (TMPeTA) (Mn 692),
trimethylolpropane tris(3-mercaptopropianate) (TMPTMP), and triethylamine (TEA) were
obtained from Aldrich. Diethylamine (DEA) was obtained with 99% purity from ACROS
organics, and pentaerythritol triacrylate (PETA) was obtained from Alfa Aesar.
2.3.2 Choosing Catalyst Concentration and Polymer Fabrication
Prior to choosing the base catalyst concentration for each acrylate listed in the
above paragraph, further experiments were performed. Twenty stock solutions were
prepared by combining PETA (9 g) with varying concentrations of DEA with respect to
the acrylate functionality ranging from 2.8-35.1%. These PETA stock solutions were
stirred for 3 hours prior to the addition of TMPTMP. Gel time was calculated based on
two methods. The first way included pumping air through a syringe containing the PETA
stock/TMPTMP solution. The time at which the air bubbles were no longer able to pass
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through the solution was set as the gel time. The second method estimated gel time
using the naked eye when the flow of the polymer ceased while simultaneously inverting
the vial.
The 16.1% DEA stock solution was studied further since it allowed for an
appropriate time range needed for mixing and application of the material or the lowest
gel time. The 3-hour stir time mentioned above needed for the synthesis of the stock
solution was determined by measuring the gel times as a function of stir time. An aliquot
of 5 grams of the stock solution was transferred to a vial then 4.731 g of TMPTMP were
added at increments of 15 minutes for the first hour then at increments of one hour until
the stir time became constant.
DEA was also used to catalyze TMPeTA(692) and TMPeTA(912) at 30.2% and
14.4% DEA mol% while TEA was used to catalyze PEGDA(575) and PEGDA(700) at
0.48% and 0.68%. The amount of DEA added was determined based on the lowest gel
times determined by Chris Bounds relative to acrylate functionality.58 Since PEGDA is
difunctional, a trifunctional amine was chosen to prevent losing acrylate functionality.
2.3.3 Mass Loss and Extract Cytotoxicity
With the catalyst concentrations optimized for gel time, PEGDA(575),
PEGDA(700), TMPeTA(692), TMPeTA(912), PETA with and without 20% HA were
subjected to mass loss and extraction testing to determine the least toxic polymer for
bone replacement. All samples were weighed to obtain the initial mass before
placement in stromal media (DMEM, 10% FBS, and 1% triple antibiotic solution). The
samples were incubated on an orbital shaker with 5 mL stromal media at 37 oC and 200
rpm/min for 7 days. The samples were removed and weighed. The initial mass (Wi) and
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the mass after the 7 day soak time (Wf) were used to calculate the relative weight%.
Relative Weight (%) is calculated based on equation (2-1)
Wi

(Eq 2-1) Relative Weight % = Wf x100%
The stromal media(extracts) from the mass loss test that the samples were
soaking in for 7 days were filtered (0.2 µm pore size) and pipetted (100 µL/well) into a
96-well plate previously sub-cultured with hASC (2,500 cells/well) and incubated in a
CO2 incubator at 37 ᵒC containing 5% CO2 for 24 hours. The cellular viability on scaffold
cultures was determined using the AlamarBlue® assay by adding 10 µL of AlamarBlue®
reagent to each well and re-incubating at 37 ᵒC in 5% CO2 for 2 h. The fluorescence
was measured at an excitation wavelength of 530 nm and an emission wavelength of
595 nm using a fluorescence plate reader. The tissue culture treated plastic 96-well
plate served as a control substrate.
2.3.4 Preparation of the Foam PETA-co-TMPTMP
From the polymers fabricated in Section 2.3.2, the PETA-based polymer (PETAco-TMPTMP) was chosen for further analysis. The preparation of the composite
material was prepared by adding 16.1% PETA/DEA stock solution to TMPTMP in a 1:1
molar functionality ratio followed by 3 hours of mixing. HA (20% wt/wt) was added to the
PETA-co-TMPTMP solution and cast into cylindrical molds (10 mm (diameter) x 10 mm
(height)). All of the hydroxyapatite was originally added to only the stock solution at 20%
w/w, but it dispersed better by splitting this amount and pre-mixing separately with the
TMPTMP and stock solution. The foamed composite copolymer was fabricated by
pouring the PETA-co-TMPTMP with HA into a 250 mL pressurized spray canister using
7 g-compressed nitrous oxide as a gaseous porogen. The foamed composite copolymer
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was expelled from the canister into the same cylindrical molds used for solid casting.
The same foamed procedure was used for the solid copolymer without HA. Another
20% HA foamed sample was prepared in vitro by foaming directly into a beaker
containing stromal cell media instead of cylindrical molds to test the impact that the
physiological solution would have on the polymerization and foam structure.
2.3.5 FTIR
The conversion of the PETA acrylate used in the thiol-acrylate reaction as a
function of time involving the in situ amine catalyzed Michael addition was measured
over a 24-hour period using a Bruker Tensor 27 FTIR. The acrylate peak at 1650 cm-1
was monitored and integrated at 1-minute intervals. Equation 2-2 shows the percentage
conversion calculation in real time, where T is conversion at a particular time interval, A
is the peak area, and To is time the in initial time at 0 minutes.
(Eq 2-2). %Conversion T =

A To -A T
A To

x100%

2.3.6 Mechanical Testing
Compression testing was performed on four specimens of each PETA scaffold
type (foamed PETA-co-TMPTMP with HA (20%), in vitro foamed PETA-co-TMPTMP
with HA (20%), foamed PETA-co-TMPTMP without HA, and solid PETA-co-TMPTMP)
at room temperature using a hydraulic universal testing machine (Instron Model 5969,
Canton, MA, USA) at an extension rate of 0.5 mm/min to a maximum compression
strain of 90%. The solid PETA scaffolds were prepped in a PDMS cylinder mold that
measured 10 mm (diameter) × 10 mm (height) and the foamed samples were prepared
in a weigh boat and cut using a 10 mm (diameter) x 10 mm (height) biopsy punch.
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2.3.7 PETA-co-TMPTMP Mass Loss and Extract Cytotoxicity
Each PETA composite copolymer-HA (foam and solid) as a function of
composition was analyzed for mass loss and extract cytotoxicity. PCL foam, prepared
through thermally-induced phase separation,59 served as a positive control, and a solid
cast PETA composite provided an internal comparison for previous experiments. The
same mass loss and extraction procedure used for the selection of polymers above was
used for the PETA samples (Section 2.3.3).
2.3.8 hASC Isolation and Culture
Liposuction aspirates from subcutaneous adipose tissue were obtained from
three donors. All tissues were obtained with informed consent under a clinical protocol
reviewed and approved by the Institutional Review Board at the Pennington Biomedical
Research Center. Isolation of hASC was performed as described elsewhere.60 The
initial passage of the primary cell culture was referred to as “Passage 0” (p0). The cells
were passaged after trypsinization and plated at a density of 5,000 cells/cm2 (‘‘Passage
1’’) for expansion on T125 flasks in order to attain 80%. Passage 2 of each individual
was used for cell viability test after acute exposure to the scaffold medium extractives
and on scaffolds after loading using a spinner flask.
2.3.9 hASC Loading on Scaffolds and Culture
5 µL (1.0 × 104 cells/µL) of Passage 2 of each donor (n = 3) were pooled and
directly seeded on the top of each sample. After 30 min of incubation at 37 ᵒC and 5%
CO2, the opposite side of each sample was loaded with the same number of cells by the
same approach. Experimental groups included: PETA-co-TMPTMP solid, PETA-coTMPTMP foam, PETA-co-TMPTMP+HA solid, PETA-co-TMPTMP+HA foam, PCL solid
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and PCL foam. Scaffolds seeded with hASCs were immediately transferred to new 48well plates and cultured in stromal media (DMEM, 10% FBS, and 1% triple antibiotic
solution) for 7 days followed by sample collection to assess cell viability with
AlamarBlue® stain.
2.3.10 In Vitro hASC Viability on Scaffolds with AlamarBlue®
The viability of cells within the scaffolds in stromal media was determined after 7
days using an AlamarBlue® metabolic activity assay. The scaffolds were removed from
culture, washed three times in PBS, and incubated with 10% AlamarBlue® in Hank’s
balanced salt solution (HBSS) without phenol red (pH 7) for 90 min. Aliquots (100 µL) of
AlamarBlue®/HBSS were placed in a 96-well plate in triplicate, and the fluorescence
was measured at an excitation wavelength of 530 nm and an emission wavelength of
595 nm using a fluorescence plate reader.
2.3.11 In Vitro hASC Viability on Scaffolds with PicoGreen®
Scaffolds were sectioned using forceps and then incubated with 0.5 mL
proteinase K (0.5 mg/mL) at 56 ºC overnight. The mixture was centrifuged for 5 minutes
at 108 G, and 50 µl aliquots of the mixture were mixed with 50 µl PicoGreen® dye
solution (0.1 g/mL, Invitrogen®) in 96-well plates. Samples were excited at 480 nm and
total DNA concentration was compared to the live control. Scaffold without cells were
used to subtract the background fluorescence emission from all readings.
2.3.12 SEM Analysis
The solid precast PETA-co-TMPTMP polymer was gelled in a 12-well plate to
form a thin layer (1 mm thickness). The polymers seeded with stem cells were fixed first
for 30 mins by 2% glutaraldehyde (GA) (made with 2parts Cocadylate, 1 part 8% GA
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and 1 part distilled H2O). The samples were subjected to a dehydration procedure by
using 30-100% ethanol solution increasing by 10% increments every 30 minutes. 100%
HDMS (hexamethyldisilazane) was added to the samples to replace the dried air and
ethanol overnight. A conductive platinum coating was applied using EMS550X sputter
coater for 2 minutes followed by standard SEM analysis. In situ and in vitro foamed
samples were also subjected to standard SEM analysis.
2.3.13 Micro-CT Analysis
Three PETA-co-TMPTMP foams were fabricated with pressurized extrusion
foaming as described with the first two foams having 0 and 20% HA content. The third
sample also had a 20% HA content, but was foamed into the beaker containing stromal
media (in vitro). Samples were sliced into 1-2 mm approximate cuboids of 10-15 mm
height. Samples were imaged with 11 keV monochromatic x-rays with 2.5 µm/px
resolution at the tomography beamline at the Center for Advanced Microstructures and
Devices (Louisiana State University, Baton Rouge, LA). Projections numbered 720
corresponding to Dq = 0.25; projection exposure time varied between 2 and 4 seconds,
but reconstruction algorithms ensure normalized data. The two different datasets are
directly comparable, both as an aggregate dataset and as slices. Reconstruction data
are 16-bit signed integer with mean air intensity scaled to zero. Pore size was measured
using ImageJ 64.
Volume renderings were produced from the 3 foamed samples 3D data using
Avizo 7.0.1 (Visualization Services Group). Two overlapping sub-volumes are rendered
simultaneously, one with a red-orange-white colormap corresponding to trithioltriacrylate foam, and the other with a blue-green colormap corresponding to HA
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inclusions. Orthogonal slices, made using ImageJ, have equal scale, brightness,
contrast, and grey map settings.
All results were expressed as mean ± SEM. Normality of the data was confirmed
using the Shapiro-Wilk test (P < 0.001). Data were analyzed with one or two-way
analysis of variance (ANOVA), followed by Tukey’s minimum significant difference post
hoc test for pairwise comparisons of main effects. For all comparisons, a P-value < 0.05
was considered significant.
2.4 PETA Characterization Results/Discussion
Thiol-acrylate chemistry incorporates nearly all the materials used in the
synthesis process into one complete network greatly reducing the risks of leaching toxic
monomers and short chain oligomers, as is observed with other techniques.61,62
Additionally, bioactive compounds such as peptides can be copolymerized as has been
demonstrated with photoinitiated thiol-acrylate chemistries.63 Third, and perhaps most
importantly, these materials can rapidly polymerize in situ and in an in vitro environment
through an attached tertiary amine, self-catalyzed ‘‘chain’’ process.
These materials have broadly tunable mechanical and chemical properties in that
many compositions of polymer chain repeating units with thiol and acrylate moieties can
be created using the same approach and biocompatible reaction scheme. By varying
the number of functional moieties, straight chain, branched, and crosslinked
compositions can be synthesized. However, for in situ polymerization to be practical, gel
times must be tunable across a range from minutes to hours, which is easily achievable
using this thiol-acrylate system. The strength of these materials can also be
manipulated by varying the initial DEA concentration, as the functionality and crosslink
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density are both a function of the DEA concentration. This is caused by the first Michael
addition with the secondary amine, which results in the loss of an acrylate functionality
to the trifunctional acrylate.
2.4.1 Determining Gel Times
The method in which the gel times were estimated by using the naked-eye to
determine when the polymer no longer flows produced shorter gel times compared to
the method using the air-flow apparatus. To prevent underestimating the gel times, the
air apparatus gel time method was used.
As shown in Figure 2-1, the PETA-co-TMPTMP gel time point decreased as the
DEA catalyst concentration increased as seen in the left hand side of the graph, which
was the expected trend due to the increased reaction rate.14 However, the gel time
started to increase between the samples containing 16.1 and 17.8 mol% DEA and
continued with increasing DEA mol%. The unexpected increase in the gel time could be
explained via FTIR analysis. Using critical % conversion equation ρc from Carother’s
theory and Flory and Stockmayer theory,
(Eq. 2-3): Flory and Stockmayer: ρc = 1/(1 + f − 2)1/2
(Eq. 2-4) Carother’s: ρc = 2/favg
it was found that increasing the DEA mol% past 17.8% caused a higher percent
conversion to be necessary for gelation. The increase in amine catalyst decreased the
acrylate functionality, which is indirectly related to ρc. Due to the loss of monomer
functionality, ρc rapidly increased thus prohibiting gelation from taking place within the
expected time.
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Figure 2-1. Gel times as a function of amine catalyst relative to acrylate functionality.

The 16.1% DEA was chosen for PETA because it produced the lowest gel time
of ~23.5 minutes. The gel times as a function of stir time increased for the first 2 hours
as shown in Figure 2-2 then became constant. A 50 mL stock of PETA and DEA was
stirred, and 5 mL of the stock was extracted at time intervals of 5, 15, 30, 45, 60, 120
,180, 240, 300, 360, and 420 minutes. TMPTMP was added to each 5 ml stock aliquot
and the gel time was calculated until it equilibrated. It was concluded that 3 hours would
be sufficient for the amine to complete a Michael addition with the acrylate.
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Figure 2-2. The gel times of 16.1%DEA/PETA stock as a function of reaction time.
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The amounts of catalyst chosen for the TMPeTA(692) and TMPeTA(912) were
based on calculated gel times from Chris Bounds,58 but the gel times obtained did not
match the trend that was noted in the PETA polymer. The gel times did not decrease
then increase. This observation will be discussed in a later chapter. TEA was used to
catalyze the PEGDA(575) and PEGDA(700) reaction to prevent a % loss of the acrylate
functionality, since a trifunctional amine cannot add via Michael addition to an acrylate.
Only a small amount is needed for a base catalyst reaction to polymerize, therefore less
than 1% TEA was used for each.
2.4.2 FTIR
It was concluded from studying the reaction kinetics using FTIR that by varying
the DEA concentration that the gel time and kinetics were somewhat related. Even
though the gel time analysis trend appears that the reaction rate decreases after the
catalyst concentration increases past 17 mol%, the FTIR disputes that observation
showing an increase in the rate at high DEA concentrations. The acrylate peaks were
integrated, and conversion was calculated to give at least 95% acrylate conversion in
less than a 24-hour period of time shown in Figure 2-3. The 2.8% DEA polymer
reached 95% conversion in 24 hours but a continued study showed that it reached a full
100% conversion in 32 hours. 16.1% DEA and 35.1% DEA reached full conversion in
the 24 hour time period.
2.4.3 Choosing Acrylate Monomer Based on Mass Loss/Extract Cytotoxicity
The PETA-co-TMPTMP polymer was chosen for further analysis as a potential
bone repair composite because the gel time could be optimized to ~20 min gel time.
PETA was the most attractive acrylate in terms of biocompatibility and mass loss data.
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Figure 2-3. The %acrylate conversion over 24 hours for the 2.8%, 16.1%, and 35.1%
DEA PETA-co-TMPTMP polymers.
In Figure 2-4, the conversion of AlamarBlue® by PETA and PETA-HA polymers is
statistically the same as the tissue culture treated plastic and PCL control samples.
The mass loss over a week of exposure to physiological solution is represented
in Figure 2-5. Both PETA and PETA-HA demonstrated greater stability than other

Figure 2-4. Relative metabolic activity of hASC in thiol-acrylate extractives as measured
by Alamar blue fluorescent conversion. Relative fluorescent units have been normalized
to live control. The asterisk indicates the sample is significantly different from the dead
control.
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experimental materials tested with similar losses to PCL. Greater physiological stability
is considered an asset in the proposed application as bone regeneration time is often on
the order of weeks to months.47 The TMPeTA polymers and composites degraded much
more rapidly than PETA, and the mass loss correlates with a possible hydrolysis
reaction that would occur at more basic conditions.

Figure 2-5. Mass loss after 7 days of incubation in stromal media. Samples are
normalized to the starting mass for each sample.

2.4.4 Mechanical Testing
Biomimicry of the complex mechanical properties of native tissues proves
elusive; native tissue presents unique mechanical properties of nonlinear viscoelasticity
and strain-dependent moduli.64 The compressive strength of human cortical and
cancellous bone are 130–180 MPa and 4–12 MPa, respectively.65 The mechanical
testing of solid/foam PETA-co-TMPTMP materials is shown in Figure 2-6. Additionally, it
was found that the maximal compressive strength of this PETA-co-TMPTMP (HA) solid
at 90% strain is 19.23 + 1.39 MPa, while the pure PETA-co-TMPTMP solid is 7.71 +
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0.09 MPa. This result indicated that the introduction of ceramics improves the
mechanical strength of the PETA copolymer similar to previously published results.66,67
The compressive strength of PETA-co-TMPTMP (HA) foam is 0.72 + 0.07 MPa while
the pure PETA-co-TMPTMP foam is 0.14 + 0.02 MPa. The foamed polymer has
decreased mechanical strength compared with the solid polymer due to the large
porosity. The mechanical properties of the copolymer polymerized in vitro, 0.84 + 0.05
MPa, and in situ, 0.85 + 0.06 MPa, in physiological media were very similar, indicating
the presence of aqueous physiological media during the polymerization and foam
structure formation has little impact on morphology and mechanical properties.
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Figure 2-6. Compressive strength of PETA foamed/solid polymers with 0% and 20%
HA. The introduction of ceramics improves the mechanical strength of the PETA-coTMPTMP copolymer.
2.4.5 Mass Balance of PETA-co-TMPTMP
The polymer samples were extracted for 7 days in the stromal medium to
determine the extent of mass loss. These extracts were later used in cytotoxicity testing.
The copolymer-HA composite foam and solid cast copolymer were found to have
significantly greater mass loss than the PCL control foam. The mass loss is believed to
occur as a result of hydrolytic chain scission in a manner similar to the degradation of
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PCL in physiological solutions.68 The PCL sample increased in mass likely as a result of
mineralization or nonspecific protein deposition (Figure 2-7). Similarly to PLLA and
PLGA, the degradation of PCL occurs by bulk or surface hydrolysis of ester linkages
resulting in a byproduct of caproic acid.69 At high concentrations of these degradation
products, local tissue acidity may increase, resulting in adverse responses such as

Relative Weight (%)

inflammation or fibrous encapsulation.47
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Figure 2-7. Mass loss of foamed samples after 7 days of incubation in stromal media.
Samples are normalized to the starting mass for each sample.
2.4.6 Cytotoxicity of PETA Extracts
PCL foam was fabricated by thermally-induced phase separation from 1,4dioxane followed by lyophilization.59 Tissue culture treated polystyrene served as a
positive control, while ethanol treated hASC served as a negative control. Cells exposed
to both the copolymer and copolymer/HA composite (solid and foam) extracts had
significantly higher metabolic activity than the dead control or cells exposed to the PCL
extract (Figure 2-8, A). The reduction of hASC metabolic activity cultured on PCL does
not correlate with a significant mass loss (Figure 2-7), indicating that this reduction in
activity is likely not related to the generation of acidic PCL degradation products. The
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technique for synthesizing the foamed version of PCL uses a harsh solvent that may not
have been removed by freeze-drying.
2.4.7 Biocompatibility Test of hASC Cells on PETA-co-TMPTMP
The ability of the PETA-co-TMPTMP polymer to support hASC cell adhesion and
short-term culture was evaluated using AlamarBlue® metabolic activity assays and SEM
to examine cell morphology. Cells were cultured on solid cast PETA and PETA-HA
(20% wt/wt) composite samples for 4 days in stromal media and assayed for fluorescent
AlamarBlue® conversion; styrene treated tissue culture plates (TCP) served as a
positive control. Compared with the positive control, hASC cultured on both the
copolymer and the copolymer-HA composite had significantly lower metabolic activity
(Figure 2-8, B).
Additionally, it appears that cells cultured on the copolymer-HA composite have
significantly lower metabolic activity than cells on the non-composite. This may be a
result of reduced metabolic activity associated with the differentiation of stem cells
exposed to HA, a known osteogenic compound and may not be indicative of reduced
biocompatibility.55 Based on Figure 2-8, C, composite and PCL foam, but significantly
lower metabolic activity than cells on tissue cultured treated polystyrene. Although the
foam PETA copolymer has a much larger surface area than solid PETA copolymer, the
results indicated that both forms of PETA copolymer supports hASC growth around the
same level compared with the positive control.
2.4.8 DNA Quantification on Scaffolds (PicoGreen® Assay)
DNA content of hASC cultured on pure PETA, PETA composite, and PCL
scaffolds was compared as a relative measure of cell viability and proliferation. After 4

31

A

B

C

Figure 2-8. Relative metabolic activity of hASC determined AlamarBlue® conversion.
Asterisk indicates the sample is significantly different from the live control. A.
Exposure to 7 day stromal media extracts from PETA-co-TMPTMP, PETA-coTMPTMP(HA), and PCL foams and solids. B. Cultured on solid cast PETA-coTMPTMP and PETA-co-TMPTMP(HA) composites. C. hASCs cultured on foamed
PETA-co-TMPTMP and PETA-co-TMPTMP(HA) composites.
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days, the highest DNA content was observed in the PETA (20% HA) scaffold, 66.7% of
the TCP control. The relative DNA content of the pure PETA-co-TMPTMP and PCL
scaffolds are 56% and 65% of the live control, respectively (Figure 2-9). The DNA
content from cells cultured on all experimental samples is similar indicating that the total
number of cells does not vary significantly with composition. This result is in contrast to
the metabolic activity results (Figure 2-8, A), which indicate a significantly reduced
metabolic activity for cells grown on composite PETA-co-TMPTMP (HA) samples. This
further supports the hypothesis that the cells on PETA-co-TMPTMP (HA) are likely in a
reduced metabolic state as a result of early stage osteogenic differentiation.70

Figure 2-9. Relative total DNA amount as determined by Picogreen® assay for hASC
cultured on foamed PETA-co-TMPTMP and PETA-co-TMPTMP(HA) composites. The
results are normalized to the live control. Astericks indicate significant difference among
the samples.
2.4.9 SEM Analysis
The PETA-co-TMPTMP foam materials were found to have a largely closed
celled structure with a pore size ranging from 200 to 300 µm (Figure. 2-10 right). A
comparative image of the cast solid copolymer of the same composition can be seen in
the left panel of Figure 2-10. The bubbles in the solid sample (Figure 2-10 left) are likely
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a result of air introduced during the mixing procedure. The size of the pores found in the
foamed sample fall within the range of pores found in native cancellous bone.71 SEM
analysis also indicates that there is no substantial difference between the in vitro and in
situ (20% HA) foamed samples in terms of porosity and morphology (Figure. 2-10, A–
D).
Morphological analysis was performed after culturing the hASC for 7 days on the
solid cast PETA-co-TMPTMP films. The cells were fixed and imaged by SEM in an
effort to evaluate the cell morphology on the thiol-acrylate copolymer. From these
images, it appears that hASCs adhere well and take on the expected spindle-shaped
during culture on the thiol-acrylate copolymer films (Figure 2-11). It is likely the thiol
groups impart a negative charge to the PETA co-polymer, potentially increasing the
adhesion, spreading, and proliferation of hASC cells on these surfaces compared with
neutral surfaces.72,73

Figure 2-10. SEM images of in vitro PETA-co-TMPTMP + HA foam (A&C) and in situ
PETA-co-TMPTMP+HA foam (B&D). Magnification is x100 (A&B) AND x1000(C&D),
scale bars are 100 and 10µm, respectively.
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At lower magnification (100x) (Figure 2-11, C), a confluent cell population is seen
spreading more or less uniformly across the surface, while at higher magnification
(1000x) the aligned spindle shaped morphology of individual cells can be clearly seen
(Figure 2-11, D). Cell free controls (Figure 2-11, A-B) are included in this image for
comparison.

Figure 2-11. SEM images of PETA solid cast polymer films (A & B) and hASC after
culture for 7 days on PETA films. Magnification is x100 (A & C) and x1000 (B&D), scale
bars are 100 and 10 µm, respectively.
2.4.10 Micro-CT Analysis
Micro-CT image data (Figure 2-12, A–C) show good contrast between HA and
polymer, confirming suitability of micro-CT as an appropriate study of the HA distribution
and pore morphology. Volume renderings (Figure 2-13, A) were generated from PETAco-TMPTMP foam 3D data using Avizo 7.0.1 (Visualization Services Group). Figure 213, B (in situ) and 2-13, C (in vitro) were generated from PETA-co-TMPTMP with 20%
HA foam 3D data. Two overlapping subvolumes are rendered simultaneously, one with
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a red–orange–white colormap corresponding to thiol-acrylate foam, and the other with a
blue–green colormap corresponding to HA inclusions. Volume renderings indicate open-

Figure 2-12. 2D slices of micro-ct images using Image J. (A) 0%HA foamed (B) In situ
foamed 20%HA (C) In vitro foamed 20%HA.
cell foam and interconnectivity. An interconnected pore structure can provide support for
cell migration, differentiation, nutrient transport,74,75 and in some cases, the formation of
blood vessels76-78 can be established in the pore network. HA inclusions with the size of
10–50 µm were aggregated showing that a higher torque and speed of the stirrer are
needed to achieve better homogeneity. Measurements using NIH ImageJ from these
datasets indicate pores ranging from 100 to 500 µm for control (0% HA) and 20% HA.

Figure 2-13. Micro-CT obtained 3D data with two overlapping subvolumes rendered
simultaneously. Red-orange-white colormap corresponds to the PETA-co-TMPTMP
foam, and the blue-green corresponds to HA inclusions. A. 0%HA foamed. B. In situ
foamed 20%HA. C. In vitro foamed 20%HA
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2.4.11 Bone Adhesive Supplementary Data
PETA-co-TMPTMP was tested for its ability as an adhesive for bone by placing
20% HA PETA-co-TMPTMP excess acrylate and excess thiol formulations in between
two deer bones obtained by the LSU FACES lab. It was subjected to shear and tensile
testing. Initially, the bond between the polymer and bone was failing quicker than the
polymer itself; therefore a hole was drilled in the bone. The two pieces of bone were
bonded together by adding 20% excess thiol PETA-co-TMPTMP to one bone and 20%
excess acrylate to the other bone. PMMA (poly-methyl methacrylate) is a FDA approved
material used for bone adhesive; therefore it was used for comparison. The results
(Figure 2-14) show PMMA has higher tensile strength, but the PETA-co-TMPTMP had
comparable shear strength, which demonstrates that the PETA-co-TMPTMP is
comparable to an already used surgical adhesive material.

Figure 2-14. Shear and tensile strength of PMMA and 20%HA PETA-co-TMPTMP
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2.5 Conclusion
The step-growth nature of the amine-catalyzed Michael addition reaction reduces
the potential for unreacted monomer or radicals from leaching into the body, as would
typically occur using a chain-growth mechanism involving a free-radical process. In situ
polymerization opens the opportunity for the development of absorbable foams for the
conformal repair of critical sized tissue defects, which can be easily delivered in the
clinical surgical setting. This represents a substantial improvement over current
synthetic polymers such as PCL or PLGA, which are foamed externally prior to surgical
insertion, and methyl methacrylate bone cements, which are largely inert, nonporous,
and permanent. The SEM analysis, mechanical testing, and micro CT data support that
there is no distinct difference between the PETA-co-TMPTMP foam made in situ and in
vitro. Although this material has many potential advantages, future work includes the
development of a homogenous HA containing polymer network, osteogenic studies and
improved mechanical strength of the foamed PETA-co-TMPTMP with varying HA
concentrations. It is clear that scaffold technology plays a critical role in the success of
the current stem cell based bone tissue engineering paradigms. Although a variety of
different materials, both ceramics and polymers, have been tested in combination with
hASC, Lendeckel et al.79 note that composite scaffolds may offer a better clinical
outcome as a result of improved mechanical and biological properties. Calcium
phosphate nanoscale ceramic particles of HA and β-TCP will be used as the inorganic
osteogenic phase and thixotropic agent in future studies.
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Chapter 3. Osteogenic, In Vivo, and Antimicrobial Study
3.1 Chapter Summary
A thiol-acrylate-based copolymer synthesized via an amine-catalyzed Michael
addition was studied in vitro and in vivo to assess its potential as an in situ polymerizing
graft or augment in bone defect repair. The blends of hydroxyapatite (HA) with
pentaerythritol triacrylate-co-trimethylolpropane tris(3-mercapto(PETA), cast as solids or
gas foamed as porous scaffolds, were evaluated in an effort to create a biodegradable
osteogenic material for use as a bone-void-filling augment. Osteogenesis experiments
were conducted with human adipose-derived mesenchymal stromal cells (hASCs) to
determine the ability of the material to serve as an osteoinductive substrate. Poly(εcaprolactone) (PCL) composites PCL:HA (80:20) (wt/wt%) served as the control
scaffold, while the experimental scaffolds included PETA:HA (100:0), (85:15), (80:20),
and (75:25) composites (wt/wt%). The results indicate that PETA:HA (80:20) foam
composites had higher mechanical strength than the corresponding porous PCL:HA
(80:20) scaffolds made by thermo-precipitation method, and in the case of foamed
composites, increasing HA content directly correlated with increased yield strength. For
cytotoxicity and osteogenesis experiments, hASCs cultured for 21 days on PETA:HA
scaffolds in stromal medium displayed the greatest number of live cells compared with
PCL:HA composites. Moreover, hASCs cultured on foamed PETA:HA (80:20) scaffolds
resulted in the greatest mineralization, increased alkaline phosphatase (ALP)
expression, and the highest osteocalcin (OCN) expression after 21 days. Overall, the
PETA:HA (80:20) and PETA:HA (85:15) scaffolds had higher mechanical strength and
cytocompatibility compared with the PCL:HA control. An antimicrobial component was
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added to the PETA:HA polymer using silver nanoparticles that brought the PETA
scaffold to the next level to prevent against common infections associated with
orthopedic surgeries. The results of the 6-week in vivo biocompatibility study using a
posterior lumbar spinal fusion model demonstrate that PETA:HA can be foamed in
vivo without serious adverse effects at the surgical site. Additionally, it was
demonstrated that cells migrate into the interconnected pore volume and are found
within centers of ossification.
3.2 Introduction
For the past several decades, the standard treatment to augment or accelerate
bone regeneration has been the implantation of bone grafts.80 Allogeneic bone grafts
that are from a donor are costly, require time-consuming bone banking procedures, and
have the potential for disease transmission. Autogenous bone grafts, coming from the
patient’s own body, have long been used as bone replacements but require additional
surgeries, which increases the risk of site morbidity and the burden on health care
providers.81 Moreover, these techniques do not address the need for a clinically
convenient and biodegradable method for conformally filling a critical-sized bone defect
while providing mechanical support and biological cues necessary to promote bone
regrowth.
The mechanical strength of scaffolds plays an important role in the tissue
regeneration process by providing structural support while healing takes place.
Synthesizing a material that has comparable mechanical properties to bone while still
maintaining other important properties needed for bone replacement remains a
challenge. In situ gelling biomaterials comprised of polyethylene glycol diacrylate
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(PEGDA), synthesized using Michael addition reactions with thiol,82 show promise as
injectable tissue replacements due to their lack of toxic degradation products.83
However, PEGDA based materials usually lack the sufficient mechanical strength for
them to be used in a bone application. A recent study presented a solution to overcome
lower mechanical strength by combining both weak and strong crosslinking networks.84
This results in a stronger hybrid copolymer due to the lower density crosslinking network
acting as an energy absorber for the highly cross-linked portion.
Artificial composite scaffolds, whether bioderived, synthetic, or hybrids, while
studied extensively as alternatives for bone grafting and augmentation, have yet to see
wide clinical adoption.85 Composite structures with calcium phosphates and magnesium
silicates encompassing the bioactive ceramic portion have been studied thoroughly to
improve both the mechanical and osteogenic properties of scaffolds but an in situ
polymerizing, biodegradable bone augment or graft with biomimetic morphology and
mechanical properties remains elusive.85-87
The introduction of artificial bone scaffolds into the body does, however, trigger
complications to arise from orthopedic surgeries causing significant infection at the
injury site. Bacterial infections caused from orthopedic surgeries are often associated
with aliphatic ester based bone grafts such as poly-L-lactic acid (PLLA) and poly-Lglycolic acid (PLGA) that exhibit in vivo degradation causing the release of acidic byproducts. By preventing the formation of bacterial colonies with improved antimicrobial
therapy, the number of amputation procedures after bone augmentation surgeries has
decreased significantly.
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An initial study conducted by our group demonstrated the formation of a porous
interconnected scaffold derived from the product of an amine-catalyzed Michael addition
polymerization reaction.9 This thiol-acrylate reaction proceeds through a nonradical,
step-growth process catalyzed by an amine/acrylate comonomer that is consumed in
the reaction and incorporated into the growing polymer. Porous composite scaffolds
made with this system were found to support human mesenchymal stromal/stem cell
growth and to possess similar mechanical properties to cortical bone.88
In order to integrate an antimicrobial portion into a highly crosslinked scaffold,
silver nanoparticles (SNPs) were chosen as an antimicrobial agent, because they offer
a safe and effective broad-spectrum defense against bacterial colonies and can be
easily incorporated into the thiol-acrylate polymer.89 SNPs also possess higher reactivity
compared to other antimicrobial agents and greater surface-to-volume ratio.90 The sulfur
found in the thiol group and silver form a bond,91,92 therefore monomers with thiol
functionality are promising for the adsorption of silver nanoparticles.
The fabrication method of a scaffold can have a substantial impact on
mechanical properties and biofunctionality by controlling porosity and interconnectivity.
These factors influence cell attachment, proliferation, extracellular matrix production,
and the transport of nutrients and wastes.59,93-96 Solid freeform fabrication, thermal
precipitation, gas foaming, and solvent casting followed by particulate leaching are the
common approaches for making porous scaffolds for bone repair.95,96 Except for gas
foaming, these methods are not readily applicable to thermoset polymers due to their
crosslinking densities and viscoelastic properties. Gas porogens and foaming
apparatuses have the potential to be readily adapted to filling conformal defects in a
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clinical environment, similar to other surgical devices in use, such as fibrin sealant 97,98
and bone putty.99
In this chapter, the in vitro characterizations of the mechanical and
osteoinductive properties are demonstrated for the gas-foamed nanocomposite scaffold
consisting of a thiol-acrylate copolymer with nanoscale hydroxyapatite (HA) inclusions.
Scaffolds were prepared using a gas-phase propellant and foaming agent to investigate
the relationship of scaffold composition to morphology, mechanical properties,
cytocompatibility, and osteogenic properties. The impact of varying HA concentration in
the pentaerythritol triacrylate-co-trimethylolpropane (PETA) polymer on morphology is
illustrated using scanning electron microscopy (SEM) and micro-computed tomography
(micro-CT) imaging. Mechanical testing was conducted to determine the compressive
yield strength and modulus of the PETA based material. PETA/PEGDA hybrid materials
are also synthesized and mechanically characterized to offer an alternative material that
is more hydrophilic. To evaluate cytocompatibility and osteogenic activity, human
adipose-derived mesenchymal stromal cells (hASCs) were used as a model cell type.
Metabolic activity, DNA content, calcium deposition, and the expression of the
osteogenic markers alkaline phosphatase (ALP) and osteocalcin (OCN) were quantified
with respect to scaffold composition.
An antimicrobial study using silver nanoparticles in the polymerization method of
the thiol-acrylate copolymer was studied using two different approaches, coating and
incorporating. A 6-week in vivo study was also conducted to assess the basic
biocompatibility of the foamed composite and the feasibility of in situ foaming for a
boney fusion model.
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3.3 Materials and Methods
3.3.1 Preparation of PETA-co-TMPTMP Materials
All chemicals were used as received: Trimethylolpropane tris(3mercaptopropianate) (TMPTMP), PEGDA(polyethylene glycol diacrylate)
(PEGDA)(575), and PEGDA(700) were obtained from Aldrich, diethylamine (99% purity)
(DEA) was obtained from ACROS organics, and pentaerythritol triacrylate (PETA) was
obtained from Alfa Aesar.
The preparation of the foamed/solid composite scaffolds were prepared by
formulating PETA with 16.1% DEA, mixing with a stir rod for 3 hours, and adding
TMPTMP in a 1:1 molar functionality as described in the previous chapter.9 Several
concentrations of copolymer PETA-co-TMPTMP (PETA) with HA were studied; the first
number in the abbreviation denotes the polymer content while the second number
provides the amount of HA found in the composite as a wt/wt percentage (100:0, 85:15,
80:20, 75:25). For this chapter, the PETA-co-TMPTMP polymer will be abbreviated as
PETA when discussing the copolymer’s concentration with the HA. The highest HA
concentration successfully obtained was 25% HA. The 30% HA sample was too viscous
to expel through the canister. The mixtures were cast into cylindrical molds (10 mm
(diameter) × 10 mm (height)) forming a solid scaffold. The foamed composite copolymer
was prepared by pouring the (PETA:HA) (150 g in total) into a 250 mL pressurized
spray canister using 7 g-compressed nitrous oxide as a gas foaming agent. The foamed
composite copolymer was expelled from the canister into the same cylindrical molds
used for solid casting.
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3.3.2 Fabrication of PEGDA Hybrids
Prior to synthesizing the PETA/PEGDA hybrids, three different PEGDA Mn
((PEGDA(250), PEGDA(575), and PEGDA(700)) were synthesized. DEA (3%) was
added to the three different PEGDA Mn. Each PEGDA monomer with DEA was added
to TMPTMP at a 1:1 ratio (acrylate:thiol). The PEGDA(700) was chosen for further
analysis. Different % DEA (1.5, 1,8, 2, and 3%) were added to the PEGDA(700)
monomer and added to TMPTMP in a 1:1 ratio(acrylate:thiol).
Four different hybrids were synthesized. The first tested all Mn’s to analyze if the
results will agree with the PEGDA polymers without the addition of PETA. The first was
formulated by mixing a 16.1% PETA/DEA stock with either PEGDA(250), PEGDA(575),
or PEGDA(700) monomer. 20 and 50% excess thiol with respect to the PETA acrylate
functionality was then added. This excess amount of thiol was added in order to react
with the PEGDA monomer to ensure that all thiol and acrylate groups were reacted in a
1:1 ratio.
The second and third hybrid formulation added PEGDA(700), % triethylamine
(TEA), PETA stock containing 16.1% DEA, and TMPTMP needed for a 1:1 reaction with
both PEGDA(700) and PETA (all acrylates). The second added all components at once.
The third separately mixed PEGDA(700)/16.1%TEA/TMPTMP and PETA/DEA (16.1%)
stock/TMPTMP, stirred 6 minutes, then added the PEGDA(700)/TEA/TMPTMP mixture
to the PETA Stock/TMPTMP.
The fourth hybrid formulation used DEA, instead of TEA, with PEGDA(700). The
TMPTMP added was calculated the same as in the previous two formulations. Different
ratios of PEGDA(700) and PETA noted by PEGDA:PETA(4:1), PEGDA:PETA(2:1),
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PEGDA:PETA (1:1), PEGDA:PETA(1:2), and PEGDA:PETA(1:4) were synthesized
based on the ratio acrylate moles of each.
3.3.3 Mechanical Analysis PETA-co-TMPTMP and PEGDA Hybrids
Solid and foamed PETA-CO-TMPTMP scaffolds, molded to a 6 mm (diameter) x
12 mm (height) cylinder, were tested to determine maximal compressive strength and
modulus. All scaffolds were subjected to compression, and the ultimate compressive
strength was reported at 30% strain. A universal testing machine was used at an
extension rate of 0.5 mm/min.
Prior to choosing the Mn of PEGDA(700), three different Mn (250, 575, 700) of
PEGDA catalyzed with 3% DEA were tested. Once PEGDA(700) was chosen, different
%DEA was used to determine if mechanical strength is affected by amine content.
PEGDA(700) 1.5, 1,8, 2, and 3% DEA were subjected to compressive testing. All four of
the main categories of hybrids described in Section 3.3.2 were subjected to mechanical
testing. The modulus was calculated by taking the slope of the most linear portion of the
stress versus strain graph before failure.
3.3.4 Micro-CT Analysis
Four PETA:HA (100:0), (85:15), (80:20), (75:25) foams were fabricated by
pressurized extrusion foaming and prepared as described previously.9 The imaging was
conducted at the Center for Advanced Microstructures and Devices (Louisiana State
University, Baton Rouge, LA) using a tomography beamline with 13 keV monochromatic
x-rays with a 2.5 µm/px resolution. Projection exposure time varied from 2-4 seconds
with Dq = 0.25 corresponding to the number of image slices (520). Reconstruction data
are 16-bit signed integer with mean air intensity scaled to zero.
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Avizo 7.0.1 (Visualization Services Group) generated the volume renderings from
the 3D data of the four foamed samples with two overlapping sub-volumes displayed
simultaneously. The blue-green colormap represents the hydroxyapatite inclusions, and
the red-orange colormap represents the copolymer foam. NIH Image J generated 2-D
orthogonal slices using the same data with a scale equivalent to that of the 3-D
rendering possessing grey map settings. An approximate pore size was also measured
using Image J. The orthogonal and micro-CT datasets are directly comparable, both as
an aggregate dataset and as slices.
3.3.5 hASC Loading on Scaffolds and Culture
hASCs were isolated based on Section 2.3.5. Passage 2 of each donor (n = 3)
were pooled and directly loaded on a single face of each scaffold type at a density of
5.0 × 104 cells/ 5 µL. After 30 min of incubation in a saturated humidity atmosphere
incubator at 37 ᵒC and 5% CO2, the same hASC dose was directly applied on the
opposite side of each scaffold. Control groups included PCL:HA (100:0) and PCL:HA
(80:20) scaffolds. Experimental groups included PETA:HA (100:0), (85:15), (80:20),
(75:25) scaffolds. Scaffolds loaded with hASCs were instantly transferred to 48-well
plates and cultured in stromal or osteogenic media for 21 days with weekly sample
collection.
3.3.6 In Vitro hASC Metabolic Activity on Scaffolds
The metabolic activity of cells within the scaffolds at 7, 14 and 21 days in stromal
and osteogenic media was measured by AlamarBlue® metabolic activity assay
(Invitrogen). The scaffolds were removed from culture, washed three times in
Phosphate Buffered Saline (PBS), and incubated with 10% AlamarBlue® in Hank’s
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balanced salt solution (HBSS) without phenol red (pH 7) for 90 min. Aliquots (100 µL) of
AlamarBlue®/HBSS were placed in a 96-well plate in triplicates, and the fluorescence
was measured at an excitation wavelength of 530 nm and an emission wavelength of
595 nm using a fluorescence plate reader. DNA content, calcium deposition, and the
expression of the osteogenic markers alkaline phosphatase (ALP) and osteocalcin
(OCN) were quantified with respect to scaffold composition by colleagues in the
Louisiana State University bioengineering department.
3.4 Materials and Methods for Antimicrobial Study
3.4.1 Antimicrobial Scaffold Fabrication
Silver nanoparticles (SNPs) were added to the polymer/HA composite using two
different methods (incorporation and coating) with preparation of the composite
described previously in Section 3.3.1. The incorporation method involved dispersing
HPC-SNPs with a size distribution of 25-75 nm in 9.3% (w/v) butanol (100, 1000, 1500
ppm) by ultrasonication. The solvent containing SNPs were combined with the
PETA/DEA/HA mixture before foaming with the TMPTMP. After adding the
PETA/DEA/HA/solvent-SNP mixture to the TMPTMP, it was placed into a 250 ml
pressurized spray canister. For the incorporation method, three solvents including
ethanol, butanol, and isopropanol were studied initially to determine if solvent selection
affected the gel time or foaming process of the polymerization.
The coating method entailed soaking the pre-formed sample in ethanol,
isopropanol, or butanol containing 1000 ppm SNPs. Adding 20% excess TMPTMP
during the polymer fabrication step and soaking for 24 hours in the SNP solvent
dispersion were steps used to prepare the PETA-co-TMPTMP antimicrobial foam. The
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foamed samples were washed with PBS to remove excess SNPs and subsequently
freeze-dried to remove any residual solvent.
3.4.2 Mechanical Testing and Silver Morphological Analysis
Compressive strength was measured for the antimicrobial and control (PETACO-TMPTMP) foam or solid using a universal testing machine. The incorporating and
coating constructs were subjected to compression testing at a rate of 0.5 mm/min until
90% extension was reached.
The SEM silver morphological analysis included, all of the scaffolds
(incorporating and coating). The samples were placed on the EMS550X sputter coater,
which applied a conductive platinum coating for 2 minutes followed by standard SEM
imaging.
3.4.3 Silver Release Study and Antibacterial Testing
The amount of silver released from each sample was determined using
inductively coupled plasma optical emission spectrometry (ICP-OES). The in vitro
contact times required for the elimination of two model organisms, Staphylococcus
aureus and Escherichia coli were investigated for the scaffolds fabricated by the two
methods.
3.5 In Vivo Study
3.5.1 Scaffold Preparation and Surgical Implantation
5 male Fischer rats (Harlan Sprague-Dawley) were randomly assigned to three
different treatment cohorts: (1) one rat was implanted with pre-sculpted (20% HA); (2)
three rats were implanted with PETA-CO-TMPTMP + 20% HA foamed in situ; (3) one
rat was implanted with PETA-CO-TMPTMP + 0% HA foamed in situ. The autoclaved
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stock/HA and TMPTMP/HA pre-polymer mixture were placed into a 250 mL pressurized
spray canister using 7 g of compressed nitrous oxide as a gas foaming agent. The
spray canister components were gas sterilized before surgery. The foamed composite
copolymer was expelled from the canister into a sterilized pan. The composite was cut
into a rectangular prism with dimensions (15 × 10 × 1 mm) for rat 1. For rats 2, 3, & 4,
the pre-polymer mixture was foamed as described previously, but foamed into a 5 ml
syringe for surgical application. The same foaming process was implemented in rat 5,
but it contained 0% HA in its formulation.
The rat posterolateral lumbar spinal fusion surgery was performed according to
previous studies.100 Prior to general anesthesia, rats were treated with a subcutaneous
injection of 0.5 mg/kg butorphanol (Torbugesic; Fort Dodge Animal Health) and 0.02
mg/kg glycopyrrolate (Robinul; Fort Dodge Animal Health, Fort Dodge, IA). In order to
induce anesthesia, rats were administered isoflurane 20 mins later in an induction
chamber. The isoflurane was maintained at 1.5% via nose cone on a Bain circuit for the
remainder of the procedure. The lumbar region was clipped and aseptically prepared
with 70% isopropanol betadine. A posterior midline skin incision was made over the
lumbar spine. Two fascial incisions were made 3 mm lateral and parallel to the spinus
processes. The L4 and L5 transverse processes were exposed using a combination of
sharp and blunt dissection that was limited to the specific area of interest. A scalpel was
used to decorticate each transverse process next to the spine. The surgical sites were
thoroughly lavaged with physiologic saline. In rat 1, solid scaffolds were placed were
placed adjacent to both sides of the spine such that they spanned between the midpoint
of each transverse process. For the remaining rats, 3 ml of the foam scaffold was
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applied so that the scaffold spanned between the center of each transverse process
next to the spine. Fascial and subcutaneous incisions were closed separately with 3-0
polyglactin 910 (Vicryl; Ethicon) in a simple continuous pattern. To prevent migration,
closure of the fascia around the implants effectively obliterated any potential space. A
subcutaneous, subcuticular suture pattern was used for skin closure (Vetbond, 3M).
Five animals were humanely euthanized by CO2 asphyxiation at 3 weeks (rat 3)
or 6 weeks (rats 1, 2, 4, 6) after surgery.101 At three weeks, no significant results were
shown in radiographs, micro-CT, or histology. Therefore, no results from rat 3 were
reported in the Results and Discussion sections.
3.6 Results/Discussion (PETA-co-TMPTMP Osteogenic Characterization)
3.6.1 Mechanical Testing
Figure 3-1 shows the compressive yield strength of the foamed HA:PETA
(100:0), (85:15), (80:20), (75:25) and solid PETA. The compressive strength of the
foamed PETA steadily increased with increasing HA content; however, the solid
samples had a slightly different trend. The addition of 15% HA resulted in a significant
increase in mechanical strength, but there is no increasing trend in yield strength with
additional HA. As such, HA:PETA (85:15), (80:20), (75:25) solid scaffolds exhibited
approximately the same compressive strength. The increase in yield strength seen in
solid samples is predictable and similar to that seen with other nanoscale polymer
fillers.67,102 As porosity played no role in the solid samples, the increase in viscosity with
increasing HA content beyond 15% did not affect the solid’s mechanical strength.
Therefore, it is believed that the porosity of the foamed scaffolds is responsible
for the different trends between solid and foamed scaffolds. As mentioned above for the
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SEM analysis increasing HA content resulted in reduced pore size and interconnectivity.
This decrease in pore size resulted in a more solid and stronger structure. Other studies
have shown a similar trend of decreasing porosity with increasing HA content.103 The
pore size decreased with increasing HA signifying the direct relationship between the
foam characteristics and mechanical strength. The solid samples’ compressive strength
did not change as a result of increasing HA content which shows that the porosity plays
a major role in compressive strength not addition of filler.

Figure 3-1. The compressive strength of PETA:HA (100:0), PETA:HA (85:15), PETA:HA
(80:20), PETA:HA (75:25), PCL (80:20), PCL (100:0), and cancellous bone.
3.6.2 Mechanical Analysis of the PEGDA Hybrids
The PEGDA hybrids were synthesized and analyzed to find an alternative to
PETA-co-TMPTMP that not only had higher mechanical strength, but also an increase
in hydrophilicity. Mechanical analysis was conducted to determine the ultimate modulus
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and compressive strength of the PEGDA hybrids and how different PEGDA(Mn), DEA
(%), excess TMPTMP, and PEGDA to PETA ratios affected mechanical strength.
Prior to formulating the hybrids, the Mn of PEGDA was chosen based on
mechanical strength. As shown in Figure 3-2, the PEGDA(700) and PEGDA(250)
exhibited relatively the same strength and modulus while the PEGDA(575) was lower in
strength. Due to having the longest backbone out of the three Mn’s, the PEGDA(700)
may have a higher chance of entangling, which may be contributing to the higher

Figure 3-2. The compressive strength and modulus of PEGDA(250)-co-TMPTMP,
PEGDA(575)-co-TMPTMP, and PEGDA(700)-co-TMPTMP.
strength.104 The PEGDA(250) took ~3 hours to gel while PEGDA(575) and PEGDA(700)
only took 5-10 minutes which may also increase its strength since the functional groups
had more time to diffuse through and form bonds. More investigation is needed to
understand the sharp decrease in gel time such as rheology to determine more
accurate gel times. The PEGDA(700) Mn was chosen for further mechanical testing due
to its gel time and higher overall mechanical strength. Changing the DEA (%) did not
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change mechanical strength significantly as shown in Figure 3-3, therefore the basis of

Figure 3-3. The compressive strength and modulus of PEGDA(700)-co-TMPTMP with
varying DEA(%).
choosing DEA was on gel time and not mechanical strength. In the next chapter, the
PEGDA(700)-co-TMPTMP polymer will be described in more detail.
For the first set of hybrids, the PEGDA monomer was added to the tertiary amine
catalyst (PETA/DEA stock solution) with 20 and 50% excess TMPTMP amounts (Figure
3-3). The (575) Mn yielded the lowest strength for both the 20% and 50% excess thiol
hybrid polymers compared to the (700) and (250) Mn (Figure 3-4). These trends agree
with the results shown in Figure 3-2 with both PEGDA(575) polymers showing a drop in
mechanical strength compared to the other two Mn This confirmed that the
PEGDA(700) will be used for the three remaining hybrids. All three formulations gelled
in less than 1 minute, therefore no further testing was performed on this hybrid set.
PEGDA(700)/16.1% TEA/TMPTMP and PETA/DEA (16.1%) stock/TMPTMP
were mixed separately to allow each to react for 6 minutes before mixing all together.
By substituting TEA for DEA for PEGDA(700), the mechanism proceeded via two
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Figure 3-4. The compressive strength and modulus of PEGDA(250,575,700)/ PETA
hybrids synthesized with 20% and 50% excess thiol
competing base-catalyzed mechanisms, which demonstrated modulus comparable to
PETA-co-TMPTMP (Figure 3-5).
Figure 3-6 shows the compressive strength and modulus for the hybrids of
different ratios of PETA to PEGDA(700). The PEGDA(700)/PETA hybrids containing the
higher ratio of PETA yielded a higher compressive strength, which is attributed to the
PETA-co-TMPTMP being a stronger polymer by itself than the PEGDA(700) polymer.
On the contrary, the third hybrid formulation, specifically the 1:2 ratio of PEGDA:PETA
that used TEA to catalyze the reaction yielded a modulus comparable to PETA-coTMPTMP(Figure 3-5). Three out of the four hybrids proved to be weaker overall than
the PETA-co-TMPTMP polymer. These hybrid materials could still offer an alternative if
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Figure 3-5. Compressive Modulus of Hybrid ratios of (PETA stock):(PEGDA(700)TEA)
a more hydrophilic polymer is needed for a particular application. For example, in the in
vivo section of this chapter, one of the disadvantages of PETA-co-TMPTMP that will be
discussed is that it did not stick to bone well, and a more hydrophilic polymer, like a
PEGDA-PETA hybrid may help address this shortcoming. The hybrids were not studied
further because they did not provide an increase in mechanical strength, therefore the
remainder of this chapter focuses on the PETA-co-TMPTMP(HA) composites.

Figure 3-6. Compressive strength and modulus of PETA 16.1% DEA, 3% DEA
PEGDA(700), and different PEGDA(700):PETA ratios
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3.6.3 Morphological (SEM)
The effect of the foaming method was examined further by expelling the foam
into a beaker filled with stromal media. The SEM imaging (Figure 3-7) of the in vitro
foamed sample had the same porous structure as the polymeric foam being expelled
into a dry mold. Nucleation of the gas porogen, nitrous oxide, cannot occur at high
viscosity. The effect the HA content had on the porosity of the foamed samples was
also studied, and it was concluded that the porosity decreased as the concentration of
the HA increased. This trend is the result of the diffusion and expansion rate of the
nitrous oxide bubbles that are released by the foaming apparatus. The gaseous bubbles
evaporate out of the polymer/HA composite very rapidly when the viscosity of the
samples is low. However, the viscosity begins to increase with each 5% increase of HA,
therefore the expansion and diffusion of the gaseous bubbles are prohibited at high HA

Figure 3-7. Scanning electron microscopy analysis of pentaerythritol triacrylate-cotrimethylolpropane (PETA): hydroxyapatite (HA) (100:0), (80:15), (80:20), and (75:25)
scaffolds.
concentrations (25 and 30%). The pore size decreased with increasing HA signifying
the direct relationship between the foam characteristics and mechanical strength. The
solid samples’ compressive strength did not change as a result of increasing HA content
which shows that the porosity plays a major role in compressive strength not addition of
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filler. The highest HA concentration successfully obtained was 25% HA. The 30% HA
sample was too viscous to expel through the canister.
3.6.4 Micro-CT
There is a limitation associated with the amount of material that SEM can
qualitatively analyze, reducing the generalizability of the data. To address this limitation,
the interconnectivity, pore volume, and ceramic phase distribution of HA-PETA
copolymer composites and PCL (control) were further analyzed by micro-CT. Micro-CT
image analysis is a more sensitive method for estimating porosity of materials when
compared to SEM, flow porosimetry, and gas adsorption.105 Volume renderings (Figure
3-8) were generated from PETA-co-TMPTMP and PCL composite foam 3D data using

Figure 3-8. Micro-CT of Avizo rendering pictures (3D & 2D). The blue-green colormap
represents the HA inclusions, and the red-orange colormap represents the copolymer
foam. (A, B) PCL:HA (100:0), (C, D) PCL:HA (80:20), (E, F) PETA:HA (100:0), (G,
H) PETA:HA (85:15), (I, J) PETA:HA (80:20), (K, L) and PETA:HA (75:25) scaffolds.
Each scale bar in the 2D pictures indicates 500 µm.
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Avizo 7.0.1 (Visualization Services Group). Two overlapping subvolumes were rendered
simultaneously, one with a red-orange-white colormap corresponding to thiol-acrylate
foam, and another with a blue-green colormap corresponding to ceramic HA additives.
3.6.5 hASC Metabolic Activity and Proliferation on Scaffolds Cultured
AlamarBlue® conversion to its fluorescent form is a convenient measure of
metabolic activity and is frequently used as an indicator of cell viability. All scaffold
samples were seeded with hASC and cultured in stromal or osteogenic media for 21
days. The AlamarBlue® conversion was measured at 7, 14 and 21 days. Among all the
scaffolds, PETA:HA (100:0) showed highest metabolic activity, followed by PCL:HA
(100:0) in osteogenic media. In stromal media, PETA:HA (100:0) scaffolds exhibited
highest metabolic activity at 7 and 14 days while PCL:HA (100:0) presented with highest
metabolic activity at 21 days (Figure 3-9). With the addition of HA to PETA-co-TMPTMP
and PCL containing scaffolds, decreased metabolic activity was observed in stromal
and osteogenic media. Significant differences in metabolic activity between stromal and
osteogenic media were observed at all-time points for PCL:HA (100:0) and PCL:HA
(80:20) scaffolds. This data is in agreement with previous studies that indicate that the
metabolic activity of hASCs is expected to decrease as cells commit to an osteogenic
lineage.59,106
As for PETA:HA (100:0) control, significant differences were only observed for 7
and 14 days. Almost no metabolic activity was measured in PETA:HA (75:25) scaffolds
likely as a result of the reduced pore size and interconnectivity reducing the number of
viable cells in the scaffold. PETA:HA samples, regardless of HA content, showed no
differences in metabolic activity between stromal and osteogenic conditions. This
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Figure 3-9. Relative metabolic activity of hASCs on PETA:HA(100:0), (85:15), (80:20),
(75:25) scaffolds in stromal and osteogenic media.
reduction in metabolic activity is common during the osteogenic differentiation of
mesenchymal stromal cells. hASC cultured on HA containing scaffolds would be
expected to begin differentiation into an osteogenic linage regardless of the media
condition, potentially accounting for the differences in metabolic activity between HAcontaining and control samples cultured in stromal media.
3.7 Antimicrobial Results/Discussion
Synthetic scaffolds containing antimicrobial components have been shown to
reduce the bacteria associated with hospital-acquired infections.107 Silver nanoparticles
(SNPs) were added to the polymer/HA composite by dispersing in different solvents in
order to develop an antimicrobial component within the biomaterial. Foaming of the
polymer with different solvents including ethanol, butanol, isopropanol, and propanol
had different effects on the polymerization process.
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Propanol decreased the polymer gel time from 20 to 5 minutes; therefore, no
further testing was performed using propanol as the SNP dispersion solvent. The
ethanol solvent caused partial aggregation of HA, but required no post-treatment.
Isopropanol also did not require post-treatment, but the nitrous oxide pores formed
collapsed quickly. The results for the solvents were likely due to solubility with nitrous
oxide and different polar interactions between the polymerization and the alcohols. The
butanol distributed HA well throughout the polymer, but it did require post treatment of
freeze-drying for complete removal. Butanol was chosen for further experimentation for
it was the only solvent that did not effect the gelation time and foaming process.
Different concentrations of butanol relative to the total amount of polymer plus the HA
amount were tested to examine the effect the different concentrations had on the
dispersion of SNPs and the mechanical compressive strength. Concentrations below
9.3% did not disperse SNPs well; therefore, the minimum concentration of 9.3% butanol
was needed for the dispersion of the SNPs. The compressive strength was not
significantly different for concentrations above 9.3% (Figure 3-10); therefore, the 9.3%
was chosen to ensure the lowest amount of solvent needed was used for the synthesis.
The incorporation method of the nanoparticle solvent solution into the prepolymer network before gelation had a significant effect on the ultimate compressive
strength by causing it to decrease compared to the control. Since the coating method
was synthesized with 20% excess thiol, the mechanical strength also dropped due to
the presence of unreacted monomers as shown in Figure 3-11. The control contained
zero solvent SNP solution and was synthesized using a 1:1 ratio of acrylate to thiol.
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Figure 3-10. Compressive strength of the polymer as a function of %butanol relative to
total HA + polymer
SEM imaging comparing the surfaces of the coating method prepared scaffolds
versus the incorporated scaffolds was performed. The silver particles are visibly shown
on the surface (Figure 3-12, A), while the incorporating appears to have no silver
particles on its surface (Figure 3-12, B).

Figure 3-11. Mechanical Analysis of foamed scaffolds prepared by the incorporating
and the coating method.
Both the incorporating and coating method samples were placed in PBS for 3
days after the silver nanoparticles were added in each way. 100 ul of PBS was removed
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every 24 hours for analyzing released SNPs from the scaffold as shown in Figure 3-13.
For studying the residual SNPs on the scaffold, the polymer was dissolved in a piranha
solution then analyzed using ICP-OES. During the 72-hour ICP-OES analysis, the

A

B

Figure 3-12. SEM imaging of polymers prepared by the (A)coating and (B)incorporating
methods.
scaffolds fabricated by the incorporating method released no detectable amount of
silver as shown in Figure 3-13, B. However, the amount of silver found within the
polymer + HA matrix steadily increased with increasing SNP concentration. The
monomers, PETA and TMPTMP, used have a small molecular weight yielding a tighter
crosslinking density, which trapped the silver within the matrix.
For the coating method, the highest silver concentration released was after 72
hours. (Figure 3-13, A) The amount of SNPs being released increased with each 24hour time point showing that the diffusion of PBS through the scaffold was relatively
slow. These trends are ideal for the defense against infection associated with
orthopedic implants. There was no statistical difference in the amount of silver released
from the different solvents (ethanol, butanol, isopropanol). The amount of silver found
within the polymer was the highest during the first 24 hours and slightly decreased over
the 72-hr study. The coating method contained a lower crosslinked network attributing
to the increased release of SNPs and the surface coated with SNPs,
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Figure 3-13. ICP-OES analysis of the released silver content and the residual SNPs
within the scaffolds prepared by the A. Coating method B. Incorporating method
Colleagues performed antimicrobial studies on each scaffolds against
Escherichia coli and staphylococcus aureus, and it was concluded that the coating
method reduced S. aureus and E. coli, while the incorporating method did not. (Figure
3-14) This is likely due to the low silver release from the incorporating scaffolds shown
in ICP-OES. The PETA-HA-SNP can be implemented in nanocomposite bioscaffolds to
create engineered, active, and antimicrobial tissue scaffolds.
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B

Figure 3-14. (A) % Reduction of the coating method(A) using various solvents against
S. aureus and E. coli. (B)% Reduction against S. aures and E.coli using different SNP
concentrations for the incorporating method.
3.8 In Vivo Results
Normal weight gain (90.7 ± 5.9 g) and behavior were observed for all rats. The
rats survived the spinal fusion surgery and up to 6 weeks post-op, which was the
duration of the experiment. Slight calcification was observed at 3 weeks after
implantation, and became more evident after 6 weeks. Compared to the rats containing
the directly injected foamed PETA-co-TMPTMP scaffolds, the rat implanted with the
pre-fabricated sample increased slower in intensity at 6 weeks after implantation. The
rat implanted with 0% HA pre-sculpted PETA-co-TMPTMP scaffolds showed little to no
calcification, which is in agreement with the in vitro osteogenesis study. This study
demonstrated that 0% HA scaffolds do not significantly induce the osteogenic markers
expression with respect to the control.
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To analyze bone formation, micro-CT was performed on the extracted spinal
defect section from each rat shown in Figure 3-15. At 6 weeks post-op, rats injected
with foamed in vivo scaffolds showed non-continuous ossified regions among the entire
defect area. During the closure of the surgical site, the foamed in vivo structure may
have separated from the spinal defect resulting in non-continuous bone formation
exhibiting poor interconnectivity and porosity.
Rat 1
(Pre-foamed)

Rat 2
(Foamed in vivo)

Rat 4
Rat 5 (0%HA)
(Foamed in vivo) (Foamed in vivo)

Figure 3-15. Micro-CT data of the L4 (top) and L5 (bottom) vertebral bodies from the in
vivo study. The light-colored regions indicate densification in scaffolds.
3.9 Discussion/Conclusion: overall
Bone tissue engineering involving polymer/ceramic composites presents an
attractive alternative approach to the repair and regeneration of damaged or
traumatized bone tissue.47,80 Several studies have previously explored the potential use
of thiol-acrylate chemistry for biomedical devices, but radical-based photoinitiators are
usually used to drive the polymerization process.34,56,59 A nonradical-based
polymerization method is potentially less cytotoxic and therefore more amenable to in
situ polymerization. The amine-catalyzed Michael addition for thiol-acrylate
polymerization described in this study has potential advantages compared to
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photoinitiated reactions because the chain propagation does not require a free radical
initiator during the polymerization reaction. The mechanism of this amine-catalyzed
reaction has been previously investigated.9,14 The general reaction occurs via the
formation of a catalyst/comonomer molecule by the Michael addition of a secondary
amine across the alkene end group found in acrylate monomers. The in situ catalyst
produced reacts with a trifunctional thiol and trifunctional acrylates forming a highdensity crosslinked copolymer. The step growth nature and the incorporation of the
tertiary amine catalyst reduce concerns about potential leaching of free-radical initiators
and unreacted monomer. This reaction, therefore, is potentially more attractive for in
situ polymerization for bone formation than comparative free-radical-based methods.
The PCL-based scaffold was synthesized via a thermal precipitation method
resulting in pore size, volume, and interconnectivity that are largely independent of
solution viscosity.108 Results showed that such characteristics were directly influenced
by the viscosity of the stock solution in the polymerization of PETA-co-TMPTMP
composites.109 It is well documented that an interconnected pore structure can help
support cell migration, cell differentiation, nutrient transport,75,74 and, in some cases,
formation of blood vessels.76-78 Because HA was found to decrease interconnectivity, it
was expected that the highest HA concentration sample PETA:HA (75:25) would not
provide a suitable environment for cell in-growth and nutrient/waste transport. Electron
microscopy images and micro-CT analysis indicate that PETA:HA (75:25) scaffolds lack
interconnectivity of the void volume providing for cell penetration and nutrient/waste
transport required for cell growth and differentiation. The analysis of cell viability and
expression of osteogenic markers further supported this hypothesis.
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The decreased metabolic activity of PETA:HA composites compared with the
PETA-co-TMPTMP control is likely related to differences in cell function, not cell
number, attributed to osteogenic differentiation of hASCs. The decreased cell
proliferation and metabolic activity also had an inverse relationship with the increased
calcium deposition and expression of osteogenic markers. This data further supports
the hypothesis that HA induces osteogenesis, resulting in decreased metabolic activity
and proliferation.110,111
Further experimentation by colleagues showed that calcium deposition correlated
with the expression of ALP and OCN in hASCs cultured on PETA:HA (85:15) and
PETA:HA (80:20) scaffolds, which were significantly greater than PCL:HA (80:20), pure
PCL, and PETA control scaffolds in both media conditions, providing a further indication
that scaffolds composed of PETA may be an appropriate material for the repair of bone
defects. Increased alizarin stain uptake in PETA:HA (80:20) and PETA:HA (85:15),
compared with PCL:HA (80:20), does not correlate with increased cell density or
metabolic activity but does correlates with increased ALP and OCN expression. PETAco-TMPTMP is better able to induce the expression of osteogenic markers than PCL,
but further comparisons at differing concentrations and with other degradable resins are
required to test this hypothesis. Cross-sectional images of PETA:HA (75:25) scaffolds
demonstrate poor alizarin red penetration, providing further support that the void volume
is not substantially interconnected.
Although increasing HA content resulted in reduced pore size and
interconnectivity, it provided a more solid and stronger structure for the scaffold. Other
studies have shown a similar trend of decreasing porosity with increasing HA
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content.103 The increase in compressive strength seen in solid samples is predictable
and similar to that seen with other nanoscale polymer fillers.102,67 As porosity played no
role in the solid samples, the increase in viscosity with increasing HA content beyond
15% did not significantly affect the mechanical strength.
By soaking the PETA based polymer in solvent containing SNPs, the coating
method was proven to be an effective way to not only transport an antimicrobial element
within the thiol-acrylate copolymer, but also to release and fight the microbes most
commonly associated with orthopedic infections. The incorporating method did not
release any silver according to the ICP-OES results leading to no defense against the
E.coli and Staph. aureaus. During the in vivo study, the structure of the in-situpolymerized foam sample may have been disrupted when the surgical site was closed
during the surgery. Poor porosity and interconnectivity could be the reason why the
densified regions of the radiographs were noncontinuous.112 Overall results suggest that
PETA:HA scaffolds could be a suitable substrate for bone regeneration.
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Chapter 4. Cell Adhesion to Thiol-Acrylate Materials
4.1 Chapter Summary
Thiol-acrylate materials have been demonstrated to have therapeutic potential as
biocompatible scaffolds for bone tissue regeneration due to their osteoconductivity,
biodegradability, and well-suited mechanical properties. This chapter connects the
mechanical properties and stability of thiol-acrylate polymer networks with cell adhesion
and proliferation of human adipose derived stromal cells. The other polymers presented
in this chapter, polyethylene glycol diacrylate (PEGDA(700))-co-trimethylolpropane
ethoxylate triacrylate-co-trimethylolpropane tris(3-mercaptopropionate)(TMPTMP) and
TMPeTA-co-TMPTMP, was synthesized by a simple amine-catalyzed Michael addition
reaction without any complicated functionalization using cell adhesive proteins.
Physical, mechanical, and chemical characterizations were performed on the polymeric
substrates, followed by preliminary in vitro cytocompatibility tests. Live/dead stain
assays showed significant differences in cell survival for TMPeTA of differing molecular
weight (692 and 912 g/mol). Collectively, these results highlight the potential for these
thiol-acrylate based polymers to be a versatile, biocompatible scaffold for tissue
engineering applications.
4.2 Introduction
The process of cell adhesion is important as it directs cell-cell communication,
migration of cells, and cell survival. The ability of stem cells to adhere to a given surface
sets the foundation for cells to organize and form highly structured tissues. Integrating a
polymer based scaffold that supports cell attachment in vitro can subsequently allow for
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in vivo tissue formation, readily addressing supply and costs associated with bone grafts
as well as providing other benefits.113
Successful cell adhesion to a substrate requires the adsorption of three protein
classes: extracellular matrix (ECM), transmembrane, and cell adhesion receptor
proteins. Surfaces that lack the ability to interact with these proteins, such as
(polyethylene glycol) (PEG), exhibit weak interactions between the substrate and the
cells preventing cell adhesion from occurring.114,115 Alternatively, PEG based materials
have been shown, as successful carriers for cell encapsulation, which is a substitute for
cell seeding for the transport of cells in vivo that does not require cell adhesion.62,116 To
address the challenges of attaching cells to polymeric surfaces, adhesive moieties such
as RGD or collagen have been used to improve cell adhesion.33,113,117,118 However, the
incorporation of RGD into synthetic scaffolds is an expensive process that includes
lengthy synthetic techniques usually followed by post-purification steps.119,120
Several polymer characteristics affecting cell adhesion in vitro and subsequently
tissue formation in vivo are wettability, mechanical integrity, and surface charge.121,122 A
hydrophilic polymer can greatly enhance cell function by aiding in the adsorption of
extracellular proteins.123 While, the surface charge of the polymer contributes to the
material’s hydrophilicity, it also affects cell adhesion by promoting interactions with
charged species in the extracellular matrix.121,124 The mechanical properties of the
polymer surface play a role in cell adhesion since cells usually attach to relatively stiff
materials by transmembrane receptors (integrins), which connect the cytoskeleton of
the cells to the substrate.125,126 This phenomenon is illustrated by a change in cell
morphology when attachment to an appropriate substrate occurs.127,128
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Prior research has explored scaffolds fabricated using pentaerythritol triacrylateco-trimethylolpropane tris(3-mercaptopropionate) (PETA-co-TMPTMP), another thiolacrylate polymer, as potential bone augments and grafts. These materials promote cell
adhesion/proliferation without the need for cell adhesive proteins or amino acid chains,
such as RGD.9,112,129 The high conversion and lack of radical production, characteristic
of these base-catalyzed, thiol-acrylate step-growth polymerizations, contribute to the
cytocompatibility of PETA and support its application as an in situ polymerizing
biomaterial, but the chemical moieties and properties of these materials that promote
cell adhesion remain to be elucidated.
The purpose of this study was to demonstrate the effect amine content, monomer
molecular weight, reaction synthetic route, and average functionality have on cell
adhesion. Several polymer compositions, in which the monomer or base catalyst
content was altered, were synthesized similar to PETA by a base-catalyzed Michael
addition reaction that proceeds by a step-growth polymerization. Along with the
TMPeTA (692 & 912) polymers, polyethylene glycol diacrylate (PEGDA) (700) polymers
will also be synthesized via nucleophile-initiated and base-catalyzed reaction routes
with different material properties analyzed. Initial characterization studies of
TMPeTA(692) and TMPeTA(912) polymers were performed to examine the mechanical
properties, hydrolytic stability, and hydrophilicity of the polymers. Live/dead staining and
PicoGreen® quantification of DNA were used to quantify the attachment and
proliferation of human adipose-derived adult stem cells (hASCs) onto the thiol-acrylate
material. A proof of concept encapsulation technique will also be presented to
demonstrate an alternative method for transporting cells in vivo.
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4.3 Materials/Methods
4.3.1 Preparation of PEGDA(700) Nucleophile-Initiated Polymers
As discussed in a previous chapter, the PEGDA(700) monomer was chosen for
further analysis due to its higher modulus and compression strength compared to the
250 and 575 PEGDA molecular weights. DEA (0.5%, 1.0%, and 2%) was added to
PEGDA(700) and shaken by hand for 1 minute. TMPTMP was added in a 1:1 molar
ratio to the PEGDA monomer. Besides the 1:1 formulations of acrylate to thiol, excess
thiol concentrations were also prepared using 10%, 20%, 30%, and 40% thiol and
added to the PEGDA(700)/DEA solution.
4.3.2 Gel Time
The gel times were calculated for the 0.5%, 1%, and 2 % DEA PEGDA(700)
samples in a 20 ml glass vial by starting the timer as soon as TMPTMP is added and
stopping the time when the PEGDA(700)/TMPTMP/DEA solution ceased to flow when
the vial was inverted.
4.3.3 FTIR Conversion Analysis
FTIR was performed on the PEGDA(700) polymers with varying amine
concentrations (0.5%,1.0%, and 2.0% DEA). The polymer precursor mixture was placed
between two KBr plates and spectra were taken every 2 minutes for 12 hours. Using
OPUSTM software (Bruker Optics, Germany), each acrylate functional peak (1618-1635
cm-1) was integrated and the area was used to determine % conversion. % Conversion
was calculated based on the following formula:
(Eq. 4-1) %Conversion T =
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PEGDA(700)/0.5% DEA/20% excess thiol samples were also tested to measure the
conversion and to quantify any unreacted monomers still present.
4.3.4 Swelling
The swelling ratio was calculated by soaking triplicates of 0.5% DEA
PEGDA(700) polymer samples in 5 ml of PBS. The samples were cured for 48 hours,
and were punched out using a 10 mm biopsy punch. The dry weight (Wd) was found
prior to submerging the samples in PBS, and the “wet” polymer weights (Ws) were
measured every hour until the sample reached an equilibrium weight, which took 10
hours.
(Eq. 4-2) %Swelling=

Ws-Wd
Wd

4.3.5 hASC Isolation and Culture
Subcutaneous adipose tissue liposuction extracts were acquired from three
donors under an approved IRB protocol (LSU#E9239). The procedure involving the
hASC isolation is described elsewhere.60 “Passage 0” refers to the primary cell cultures
initial passage and is denoted as p0. The hASCs were trypsinized, split, and plated at a
density of 5000 cells/cm2 (“Passage 1”) for expansion on T125 flasks to attain 80%
confluency. For all cell-based tests, passage 2 was used.
4.3.6 Cell Seeding on Solid Constructs
Prior to polymerization, the monomers were sterilized by filtering through a 0.45
µm nylon syringe filter (Celltreat). After sample preparation according to Section 4.3.1,
the 8 sample groups were immersed in stromal media (Dulbecco’s modified Eagle’s
medium (DMEM/F12), 10% FBS (Fetal Bovine Serum), 1% triple antibiotic solution) for
24 hours. hASCs were added to each sample with the concentration of 50,000 cells/well
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in a 48 well plate then incubated at 37 °C for a set amount of days depending on the
specific experiment.
4.3.7 Cell Morphology Analysis Using Scanning Electron Microscopy
HASCs were seeded according to Section 4.3.6 on the 0.5% DEA polymer for 24
hours. After the allotted incubation time, the stromal media was removed and the
preparation for SEM began. The following protocol was used for cell fixation to image
cell morphology on the 0.5% DEA PEGDA(700) 1:1 polymer:
1.

Add 2% Glutaraldehyde(GA) (2 parts cocadylate (buffering agent), 1 part 8% GA,

1 part DI water) to scaffolds; wait overnight
2.

Add 30% ethanol, 50% ethanol, 70% ethanol, 80% ethanol, 90% ethanol, 100%

ethanol; wait 30 minutes in between each ethanol addition
3.

Add 1:2 HDMS:ethanol; wait 30 minutes

4.

Add 1:1 HDMS:ethanol; wait 30 minutes

5.

Add 100% HDMS; wait 30 minutes

The above protocol was repeated for a second trial. FAA (formalin, ethanol, and acetic
acid) fixative was used for the third trial in place of GA. FAA fixation was repeated. For
the next trial, CO2 drying was used in place of adding HDMS in steps 3-5.
4.3.8 AlamarBlue® of PEGDA(700)
AlamarBlue® was used to test the relative metabolic activity of cells seeded on
PEGDA(700) 0.5% DEA 1:1(acrylate:thiol) polymers, (polycaprolactone)PCL solid, and
a positive control after 3 days of incubation at 37 °C. The positive control consisted of
hASCs seeded onto the tissue-cultured well plate and the PCL was obtained from
SIGMA Aldrich, melted flat onto the well plate. For the 7 day study, 10, 20, 30, and 40%
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excess thiol concentrations were tested along with 0.5% DEA PEGDA(700)1:1
polymers.
4.4 Materials and Methods (PEGDA(700) Base-Catalyzed)
4.4.1 Polymer Preparation
DEA % (1.0, 2.0, 3.5, 5.0, 7.5, and 9.0) were added to PEGDA(700). 7.5% and
10% PBS (relative to PEGDA(700) weight) was added to the PEGDA(700)/DEA stock
solution and stirred for 24 hours. TMPTMP was added in a 1:1(acrylate:thiol) molar ratio
including the percentage amine that reacted with the acrylate into the calculation.
4.4.2 Gel Time and Swelling
The gel time was measured based on the method described in Section 4.3.2 for
each polymer synthesized in Section 4.4.1. The swelling ratio at one hour was
calculated for each polymer synthesized in Section 4.4.1 based on the initial mass (Wd)
and the mass after the polymers were soaking in PBS for one hour (Ws). The equation
used for the %swelling calculation is found in Section 4.3.4.
4.4.3 Mechanical Strength
PEGDA(700) polymers catalyzed by 1%, 2%, 3.5%, 5.0%, 7.5%, and 9% DEA
were gelled in a cylindrical mold and subjected to compressive mechanical testing after
48 hours of cure time. Cylindrical solids with dimensions of 45 mm (diameter) × 25 mm
(height) were tested to determine maximal compressive strength and bulk modulus.
Scaffolds were subjected to compression testing at 90% strain. A universal testing
machine (Instron Model 5696, Canton, MA, USA) was used at an extension rate of 0.5
mm/min.
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4.4.4 AlamarBlue® on Extracts of PEGDA(700) Base-Catalyzed Polymer
The stem cells were isolated and seeded according to Section 4.3.4 directly on a
48 well plate. Prior to polymerization, the monomers were sterilized by filtering through
a 0.45 µm nylon syringe filter (Celltreat). After sample preparation according to Section
4.4.1, 6 PEGDA sample groups (1, 2, 3.5% DEA with 7.5% PBS and 10% PBS) were
immersed in 5ml stromal media (Dulbecco’s modified Eagle’s medium (DMEM/F12),
10% FBS (Fetal Bovine Serum), 1% triple antibiotic solution) for 7 days. hASCs were
added to each well plate’s surface with the concentration of 50,000 cells/well in a 48
well plate then incubated at 37 °C for 24 hours. 300 µl of the media that the polymer
samples were soaking in were extracted and placed in the well plates with previously
seeded cells. These extracts were tested for cell viability 24 hours later using
AlamarBlue®.
4.4.5 Live/Dead Staining
To assess the viability of hASCs on the polymer scaffolds, live/dead staining
(Cell viability®, Invitrogen- using a Leica TCS SP2 spectral Confocal) was performed 24
hours after cell seeding. The following polymers were tested: PEGDA (2, 5, 9% DEA),
PETA (2.8 and 16.1% DEA), and TMPTA (2.8% and 16.1% DEA) with each having 10%
PBS added initially to synthesize the stock solution containing the acrylate plus DEA
with the exception of PETA. 300 µl of PBS containing 4 µM EthD-1 and 2 µM CalceinAM (Invitrogen) was added to each sample followed by incubation at room temperature
for 45 min. The samples were then imaged using a fluorescent microscope (Zeiss
SteREO Lumar.V12 fluorescence stereomicroscope) to detect live (green) and dead
(red) cells on the samples.
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4.5 Materials and Methods (TMPeTA(692&912))
4.5.1 Preparation of Thiol-acrylate Materials (TMPeTA(692&912))
All chemicals were used as received. Trimethylolpropane ethoxylated triacrylate
(TMPeTA) (692 & 912) and trimethylolpropane tris(3-mercaptopropianate) (TMPTMP)
were obtained from Sigma Aldrich. Diethylamine (DEA) was obtained with 99% purity
from ACROS Organics. The DEA was added to TMPeTA/PBS (wt% relative to acrylate
amount) with increasing mol% relative to acrylate functionality forming a stock solution.
The polymer was prepared by adding TMPTMP to this TMPeTA/DEA stock solution in a
1:1 molar functionality of acrylate to thiol. Eight different sample groups were fabricated
for the following characterizations with 692 and 912 TMPeTA with 2.8, 5.0, 10, 16.1%
DEA.
4.5.2 Mechanical Testing
The procedure described in Section 4.4.3 was repeated for all 8 samples of
TMPeTA(692) and TMPeTA(912) polymers. Cylindrical solids of the polymers with
dimensions of 45 mm (diameter) × 25 mm (height) were tested to determine maximal
compressive strength and bulk modulus at 90% strain at an extension rate of 0.5
mm/min.
4.5.3 Contact Angle Measurement
Contact angles were determined using VCA Surface Analysis System with
Optima XE software for the 692 and 912 TMPeTA fabricated with 2.8, 5.0, 10, 16.1%
DEA relative to acrylate functionality. Nanopure water (5 µl) was dispensed
automatically and allowed to equilibrate for 30 seconds on three separate locations of
each polymer sample.
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4.5.4 Mass Loss
The 692 and 912 TMPeTA with 2.8%, 5.0%, 10%, 16.1% DEA polymer samples
were fabricated as noted above and punched into cylinder shaped (10 mm (diameter) x
10 mm (height)) constructs. The samples were freeze-dried for 24 hours, then
submerged in 5 ml DMEM/F12 media for 7 days at 37 °C. The samples were washed
and freeze-dried after the 7-day incubation to remove any absorbed moisture.
4.5.5 Live/Dead Staining
Live/dead staining (Cell viability®, Invitrogen – using a Leica TCS SP2 spectral
Confocal) was performed to assess the viability of hASCs on the solid constructs 1, 4
and 7 days after seeding. The solid constructs were prepared as in Section 4.5.1, which
included TMPeTA(692) and TMPeTA(912) catalyzed by 2.8%, 5%, 10%, 16.1% DEA.
The live dead staining was prepared and imaged according to Section 4.4.5.
4.5.6 Quantification of DNA on Polymeric Samples
Total DNA content was used to determine the proliferation of cells on each
sample. All the samples were lysed using 0.5 mg/ml of Poteinase K overnight at 56 °C.
DNA quantification was done by mixing 50 µl of the Proteinase K solution and 50 µl of
PicoGreen® dye solution (Invitrogen™Quant-iT™ PicoGreen® dsDNA Assay Kit) in 96
well plates.9 100 µl of dye was used as a background and was subtracted from the data.
Samples were excited at 480 nm with an emission wavelength of 520 nm, and the total
DNA concentration was compared to a standard curve generated from serial dilutions of
hASC in order to calculate the number of the cells in each well.
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4.6 Results/Discussion
PEG-based scaffolds have shown promise in the field of bone tissue engineering
due to their similarity to the extracellular matrix and their biocompatibility.117 Most thiolene synthesized PEG hydrogels are converted to solid 3D hydrogels by way of
photopolymerization.61,130,131 However, the swollen 3D structures lack the mechanical
strength needed for bone replacement applications. Despite the low mechanical
properties, PEG monomers still remain attractive for biomaterial synthesis by aiding in
the attachment of the scaffold material to osteogenic tissue. The hydrophilicity of the
PEG network can be manipulated by changing the monomer molecular weight, which
changes the hydrophilic backbone length.
The synthesis of neat PEGDA stocks was experimented with similar to the PETA
polymer by attempting a Michael addition of DEA to the PEGDA monomer followed by
stirring for 3 hours. No gelation occurred after TMPTMP addition. The gel times did not
yield the bell curve plot that was shown for gel times of the PETA polymer graph (Figure
2-2) that illustrated a decrease in gel time then a switch to increasing gel time. T his
unusual observation of the system not gelling was analyzed further. Despite decreasing
and increasing the stir times of the PEGDA/DEA solution, gelation only occurred after
adding the DEA to the PEGDA immediately prior to adding the TMPTMP. It was likely
that the amine was not adding on to the acrylate as in the PETA system described in
chapter 2, thus free DEA molecules were evaporating due to its high vapor pressure;
therefore, the addition of the thiol did not cause it to gel. Also, the Michael addition
reaction of the amine to the acrylate may be slower than the evaporation of the amine.
Since the formation of a tertiary amine catalyst (stock solution) proved not as simple as
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for the PETA system, a nucleophile-initiated system was synthesized and characterized.
The gel times, % acrylate conversion132, and swelling ratios were measured.
Additionally, SEM imaging was used in conjunction with cell fixation techniques to study
cell morphology.
4.6.1 Gel Time and FTIR (Results)
The gel time ranged from 1-7minutes for the samples (Figure 4-1) showing a
decrease in gel time with increasing amine catalyst. FTIR was used to determine
conversion of acrylate groups as a function of time for the polymer formulations using
0.5%, 1.0%, and 2% DEA. The % acrylate conversion was determined via the equation
described in Section 4.3.3. The acrylate conversion (Figure 4-2, A) for the 1.0 and 2.0%
DEA PEGDA(700) polymer reached an average of 90%. The 0.5% DEA yielded an
average conversion of 97%.
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Figure 4-1. Gel time as a function of DEA concentration for the PEGDA(700)
nucleophile-initiated polymers.
The 1 and 2% DEA concentrations reached gelation in ~1-2 minutes which may
affect diffusion of the reactive groups likely causing the lower conversion while the 0.5%
gelled in 6 minutes allowing more time for the functional groups to react before gelation
significantly causes a decrease in diffusion of the molecules. Since the 0.5% DEA
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PEGDA(700) polymer reached the highest acrylate conversion, it was the only
concentration studied for the swelling and cell studies. The 20% excess thiol
concentration and the 1:1(acrylate:thiol) over ~12 hours were both subjected to FTIR
testing to compare the rate of acrylate conversion between the two formulations (Figure
4-2, B). The excess thiol polymer behaved as expected with the acrylate groups being
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Figure 4-2. The acrylate (%) conversion as a function of time studied using FTIR. A.
0.5%, 1%, 2% DEA PEGDA(700) polymers B. 0.5% DEA PEGDA(700) 20% excess
thiol and 1:1.
consumed immediately. Having more thiol present caused the acrylates to increase in
conversion because any unreacted acrylate would be consumed by the excess thiol
present.
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4.6.2 Swelling Ratio
The swelling ratio (%) reached 60% for the 0.5% DEA PEGDA(700) polymer over
10 hours (Figure 4-3), which is relatively low compared to other biomedical materials
used for tissue engineering that usually swell to an average % swelling ratio between
200-300%.133 On the contrary, the PETA did not swell over the 10-hour time study,
which coincides with it not having the hydrophilic ethoxylated backbone found in
PEGDA molecules that is responsible for PEG based materials swelling.

Figure 4-3. Swelling ratio of PEGDA(700) and PETA polymer over a 10-hour time
period
4.6.3 SEM (Cytotoxicity)
SEM dehydration methods of fixing cells prior to electron microscopy imaging is
important in order to preserve the cellular structure in its living state. The fixation
process is time-consuming and expensive, therefore choosing the right fixation method
is important. The theory behind cell fixation is an ongoing study, but it is generally
understood that it involves the crosslinking of proteins with other molecules found within
the cells and ECM being secreted.134 Glutaraldehyde (GA) and FAA (formaldehyde,
acetic acid, and alcohol) were the main fixatives used in the SEM cell preparation work
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with each having its own advantages. GA is considered a better crosslinker than
formaldehyde because it rapidly forms intra and inter molecular bonds with proteins and
surrounding tissue. GA yields a higher crosslinking density because it has two aldehyde
groups versus the one aldehyde group in formaldehyde. FAA fixes cells by crosslinking
too but also penetrates the cells faster since formaldehyde is smaller in size. The
alcohol and acetic acid component contained within FAA gives it an added feature by
helping keep a balance between the swelling (acetic acid) and shrinkage (alcohol) of the
cells.
The fixation step is followed by the dehydration step to remove any water left in
the sample using ethanol or acetone, and thus can be placed under the vacuum in the
SEM. Another common drying method, critical point drying, works by replacing water
with CO2 gas.135 The chemicals used in microscopy fixation protocols are known for
their harsh effects on materials and surface topology. Different cell image preparation
techniques were used to determine which method would not alter the polymer surface;
therefore GA, FAA, and CO2 drying techniques were used.
Excess thiol concentrations (10, 20, 30, and 40%) and 1:1 (thiol:acrylate) were
synthesized, seeded with cells, and imaged to analyze cell attachment on the different
PEGDA(700) formulated polymers all catalyzed with 0.5% DEA. According to SEM
imaging (Figure 4-4, B&C), the stem cells were inconsistently attaching to the 1:1 thiolacrylate formulation, but no attachment was observed on the 20% excess thiol polymer
despite the different fixation protocols used. This is contradictory to research that
reports thiol would promote cell attachment by forming disulfide bonds with thiol
containing proteins secreted by the ECM when cells begin to attach.136 The FTIR results
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(Figure 4-2, B) also showed the complete conversion of the acrylate monomer (known
toxicity) quickly when excess thiol is present which could perhaps help the overall
toxicity of the polymer. The 20% excess thiol sample displayed lower cell viability likely
due to the acidic nature of the excess monomer, TMPTMP. Similar monofunctional
thiols, ethyl 2-mercaptopropionate and methyl 3-mercaptopropionate, were studied by
Chan et.al., and shown to have a pKa of 9.66 suggesting the pKa of TMPTMP should be
similar.8
Polymers without stem cells were also analyzed for comparison of the different
methods. The polymers treated with GA showed a rippling effect on the surface, which
is usually indicative of dehydration while the FAA treated polymers presented darker
and lighter stripes on the surface resembling an inhomogeneous sample. (Figure 4-4, A)
The CO2 drying appeared to keep the polymer surface the smoothest. For the 1:1
PEGDA(700) samples, cell fragments were observed among the different protocols
except one random trial using FAA shown in the boxed column in Figure 4-4, B.
However, these results were unable to be replicated; cells on the excess thiol did not
exhibit the proliferated spindle shaped cell morphology but rather disconnected cell
pieces. Analyzing cell attachment by SEM proved to not only be time consuming but
also affected the surface topology of the polymer. Therefore, cell morphology was
analyzed by live/dead staining for the next set of experiments.
4.6.4 AlamarBlue® Results: PEGDA(700) Nucleophile-Initiated
AlamarBlue® is a cytotoxicity test that uses live cells to reduce its active
ingredient (resazurin) to a fluorescent compound. The higher the fluorescence, the
higher the number of live cells found on the samples. AlamarBlue® testing was
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Figure 4-4. SEM imaging using different cell fixatives and drying (GA, FAA, and CO2
drying) on (A) 1:1 PEGDA(700) 1:1 without stem cells (B) 1:1 PEGDA(700) with
hASCs 1:1 (C) 20% excess thiol
performed on hASC seeded samples including PCL, PEGDA polymer, and a positive
control after 3 days of incubation time. The 1:1 PEGDA polymer showed a 50%
metabolic activity compared to the 70% that PCL displayed. Seeded studies using
hASCs were also done for a samples set containing a 1:1 ratio (acrylate:thiol), 10%,
20%, and 40% excess thiol after 7 days to determine if increasing or decreasing the
excess thiol concentration would alter the cytotoxicity results. The 20% excess thiol
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concentration polymer agreed with the SEM results with only a 25% metabolic activity
revealed. The 10 and 40% did not display any higher metabolic relative activity as
shown in Figure 4-5. It should be noted that the 1:1 polymer sample dropped in
metabolic activity from day 3 to day 7 suggesting that the seeded cells on the polymer
were dying.

Figure 4-5. Relative Metabolic Activity of 1:1 PEGDA(700)-co-TMPTMP and differing
excess thiol concentrations at hASCs at day 3 and 7.
4.7 Results: PEGDA (Base-Catalyzed)
The poor results from cell studies involving the PEGDA(700) nucleophile-initiated
(1:1 and excess thiol) polymer caused a change in direction for the project. Since
PETA-co-TMPTMP was effective at promoting cell-growth, the development of the stock
solution (tertiary amine catalyst) formed from a Michael addition between an acrylate
and nucleophilic amine was re-evaluated. The structure of the PETA monomer contains
an hydroxyl group which may be responsible for donating the proton during the
formation of the tertiary amine catalyst (Scheme 1-3).8 Minimal PBS content (0.5%
relative to PEGDA weight) was added and tested via FTIR to ensure addition occurred.
The sample was prepared by adding PEGDA(700) to % PBS, mixing for 30 seconds
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then adding 20% DEA. Figure 4-6 shows the % acrylate conversion reached ~18%
conversion in under 5 hours, which correlates with the 20% DEA that was added to
synthesize the stock solution with a 2% likely attributed to evaporation. By adding a
proton source to the PEGDA(700)/DEA system, the amine adds on similar to the PETA
system.
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Figure 4-6. The percentage acrylate conversion determined via FTIR of PEGDA(700)/
PBS/20% DEA as a function of time.
For the remaining experiments, 7.5% and 10% of water relative to the amount of
PEGDA was added to make a stock solution. Prior to adding a proton source, the
samples synthesized for cytotoxicity were a mixture of base-catalyzed and nucleophile
initiated synthesized polymers since the amine could only add on to the acrylate when
the thiol (acidic hydrogen source) was available.
4.7.1 Gel Time
The samples synthesized via a base-catalyzed mechanism with 10% PBS
relative to PEGDA(700) have gel times ranging from 5-35 minutes decreasing as the
DEA concentration increased (Figure 4-7).
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Figure 4-7. Gel time as a function of amine concentration for PEGDA(700) basecatalyzed system
4.7.2 Swelling/Mechanical Strength of Base-Catalyzed PEGDA Polymer
The % swelling ratio increased for PEGDA(700)-co-TMPTMP polymers with
increasing DEA concentration (Figure 4-8B). This is related to crosslinking density
decreasing with increasing amine content since the amine performs a Michael addition
with the double bond thus decreasing acrylate functionality. In contrast, the compressive
strength decreased with an increase in DEA concentration (Figure 4-8, A). This
coincides with the crosslinking density and is in agreement with the swelling data. A
polymer will absorb more water and drop in mechanical strength as the functionality
decreases, which can occur as you increase DEA. Only the compressive strength was
reported for the PEGDA polymers since each exhibited low moduli of less than 1MPa
due to their elastic nature. Similar elastic materials display the same trend.
4.7.3 Extract Cytotoxicity of Base-Catalyzed PEGDA polymer
To determine if the PBS concentration in the stock solution would cause a
difference in the cytotoxicity results, the extract cytotoxicity was measured for samples
consisting of 1, 2, and 3.5% DEA with 7.5% and 10% PBS. There was no significant
difference in the metabolic activity between the two different PBS concentrations, which
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Figure 4-8. A. Swelling % ratio at 1 hour B. Compressive Strength of PEGDA polymers
of varying DEA (%)
is expected since PBS is a well-known buffer used in biological systems for many

Metabolic Activity

different applications (Figure 4-9).
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Figure 4-9. The cytotoxicity of the extracts from the PEGDA polymer to study the
difference between the PBS content.
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4.7.4 Live Dead Staining
PEGDA(700) 2%, 5%, and 9% DEA was seeded with hASCs and stained/imaged
at 24 hours post seeding to allow for attachment. These three DEA concentrations were
chosen to get an overview of amine composition in regards to cell attachment. The
change in morphology from sphere to spindle shaped is indicative of cell adhesion on
surfaces. Cells on PEGDA(700) and TMPTA did not show a change in morphology
while cells on PETA did change in morphology. The cells seeded onto the PEGDA-coTMPTMP polymer described earlier, maintained sphere morphology after 24 hours
(Figure 4-10). The cells on the TMPTA did not change morphology, but cells on PETA
changed morphology to spindle shape, demonstrating that cell adhesion may not be
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B

C

Figure 4-10. Live/Dead staining of hASCs on different polymers. A. PEGDA(700) 2%,
5%, 9% DEA B. 2.8% and 16.1% DEA PETA C. 2.8% and 16.1% DEA TMPTA
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dependent on crosslinking density alone. TMPTA and PETA have similar MW’s and are
both trifunctional differing only by a methyl group and a hydroxyl group suggesting
another property, wettability may be a factor in cell adhesion. Wettability in relation to
cell adhesion is discussed in more detail in the results and discussion (Section 4.8) for
the TMPeTA(692) and TMPeTA(912).
4.8 Results Material Characterization (TMPeTA 692 & 912)
Thiol-acrylate polymers synthesized via Michael addition were studied further to
understand why the adhesion of stem cells occurs to their surface without modification
or functionalization with cell adhesive peptides. As shown in the mechanism (Scheme 41), the scheme begins with the formation of a tertiary amine catalyst by the Michael
addition of an amine to the alkene group found within an acrylate. This tertiary amine
acts as a semi-strong base deprotonating the thiol and starting the polymerization
reaction. The thiolate anion adds onto the acrylate’s double bond forming a crosslinked
polymer network. As the concentration of the tertiary amine catalyst increases, so does
the rate of the reaction, which allows for tunable cure times and other properties
depending on the application.14 These anionic step-growth polymerization reactions lack
a termination step, which reduces the concentration of unreacted monomers left in the
cured material. This property is important to the cytocompatibility of a substrate, but
characteristics including hydrophilicity, crosslinking density, and chemical composition
have greater influence on the adhesion and differentiation of cells.
The extent of crosslinking of a substrate plays a significant role in the anchoring
of stem cells to biocompatible materials by providing mechanical feedback to the
cells.125 The cells exert tractional forces and gauge the feedback during substrate
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Scheme 4-1. The base-catalyzed Michael addition step growth polymerization
reaction scheme. The first step denotes the synthesis of the tertiary amine catalyst.
adhesion and locomotion, thus the substrate needs to be able to withstand these forces
for further spreading and proliferation of cells.126 Therefore, lightly crosslinked
substrates cause a delicate cytoskeleton to be formed from the weaker forces that are
exerted by the cells.
Cell adhesion on highly crosslinked substrates allows the generation of greater
numbers of focal adhesion sites resulting in cell adhesion and spreading137 (Figure 411). Cell morphology is rounded on soft substrates (Figure 4-11), indicating poor cell
adhesion, whereas the cells are more spindle shape on day 1 on the TMPeTA(912)
correlating to its inability to form an organized cytoskeleton. These weak cytoskeletons
cannot support the extent of tissue regeneration needed for bone tissue.138
Since Young’s modulus and crosslinking density are related139, the compression
modulus was determined for each of the polymers to verify the correlation between the
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Figure 4-11. Live/dead fluorescence imaging of hASCs on A. TMPeTA(692) at day 1,
4, 7 and TMPeTA(912) at day 1. B. PEGDA(700)-co-TMPTMP with 2.8% DEA after 1
day.
cross-linking of the polymer network and cell attachment. Figure 4-12 shows a decrease
in modulus with increasing amine for both TMPeTA(692) and TMPeTA(912). The
varying amine content did not have an effect on cell proliferation for the TMPeTA(692)
and (912) samples over the 7 day study. Figure 4-12 also illustrates that the
TMPeTA(692) possessed an overall higher modulus compared to TMPeTA(912) due to
TMPeTA(692) having a shorter backbone compared to TMPeTA(912). The shorter
backbone yields a more tightly crosslinked network which may be responsible for the
increase in cell adhesion on TMPeTA(692) compared to TMPeTA(912) (Figure 4-
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12).140,141 This correlates with crosslinking density as PEGDA(700)-co-TMPTMP
synthesized in Section 4.4.1 is a less crosslinked polymer compared to the tri-functional
TMPeTA containing system. The PEGDA polymers, also according to Section 4.7.2
displayed a modulus of less than 1 MPa, which may contribute to its low cell
attachment. This data is consistent with previous studies wherein the higher the
average functionality of a polymer, the higher the overall crosslinking density of the
network.142

Figure 4-12. Young’s Modulus as a function of DEA concentration for TMPeTA(692)
and TMPeTA(912).
A previously studied thiol-acrylate system, PETA-co-TMPTMP, was shown to
support cell adhesion by SEM and proliferation over a 7-day study. The PETA monomer
has an average functionality of 3 and does not have a repeating group as in the
monomer, PEGDA(700). This yielded an even tighter crosslinked polymer compared to
both TMPeTA and PEGDA containing polymers. As described in a previous section,
cells on TMPTA did not exhibit a change to spindle morphology despite it having the
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same structure as PETA minus the hydroxyl group suggesting more than one property
must be analyzed to predict its adhesion to stem cells.
Wettability is another factor that affects cell adhesion on polymeric substrates. It
was reported that a moderate wettability that had contact angles ranging from 20-40
degrees is desired to promote the adhesion of cells, where more
hydrophobic/hydrophilic substrates do not support cell adhesion well.143,121 Hydrophilic
surfaces such as tissue culture polystyrene adsorb more proteins, such as fibronectin,
than hydrophobic materials. Watchem et al. studied the effect of wettability on polymeric
substrates used in tissue engineering, such as PMMA (poly(methyl methacrylate)),
PLLA (poly-L-lactic acid) and TCPS (tissue-culture polystyrene), and observed
increasing cell adhesion with increasing contact angles.144
Figure 4-13 shows the initial contact angles for TMPeTA(692) and TMPeTA(912)
polymers ranging between 28-45 degrees with an increase in hydrophilicity with
increasing amine content. This is likely a result of the amine catalyst formed in the first
step of this polymerization increasing the polarity of the overall polymer. Another factor
contributing to its hydrophilicity is the ethoxylated repeating groups contained within the
monomer, TMPeTA.145 However, decreased cell adhesion was noted on polymer
substrates that exhibit contact angles below 30 degrees, which supports the hypothesis
that the TMPeTA (912) may be too hydrophilic for sustained cell attachment.146 As
previously discussed, TMPTA did not display a change in morphology while PETA did.
This may be attributed to PETA containing a hydroxyl group for its fourth arm while
TMPTA contains a methyl group making TMPTA less hydrophilic.
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Surface charge also contributes to cell adhesion as a result of the interaction of
charged proteins, such as extracellular matrix, and the substrate. Many commercially
available culture flasks and dishes used for cell proliferation experiments are coated
with poly-L-lysine, which also contains a charged amine functional group.147 The

Figure 4-13. Contact angles of TMPeTA(692)-co-TMPTMP and TMPeTA(912)-coTMPTMP with varying %DEA
chemical composition of the TMPeTA polymers includes the incorporation of the amine
catalyst, shown in the first step of Scheme 4-1, which is integrated into the polymer
network. The tertiary amine catalyst formed is positively charged at physiological pH
causing an overall positive charge to the polymer. This increase in overall charge with
respect to amine content may explain in part why the 16.1% DEA TMPeTA(692)
polymer promotes cell attachment/proliferation while the 2.8% DEA TMPeTA(912) does
not promote attachment despite both polymers yielding similar contact angles and
modulus.
The degradation of well-studied polymers such as PCL and poly-lactic-co-glycolic
acid copolymers (PLGA) have been shown to affect the cell adhesion/proliferation of
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stem cells.148 The disruption of the crosslinked network in ester containing monomers
(TMPeTA, PLGA, and PCL) has been shown due to the hydrolysis of the ester bonds in
acidic or basic environments.149 The change in mass over 7 days was measured for
each DEA concentration in TMPeTA(692)-co-TMPTMP and TMPeTA(912)-co-TMPTMP
to study how mass loss may affect their ability to adsorb proteins needed for cell
adhesion (Figure 4-14). Despite the 16.1% DEA 692 polymer having a mass loss of
~10%, it was able to sustain attachment/proliferation. This is likely due to the overall
increase in charge per surface area from the in situ catalyst found on the smaller
monomer (692) compared to the 912 monomer.

Figure 4-14. The degradation profile of TMPeTA(692) and TMPeTA(912) as a
function of DEA mol(%) and TMPeTA(Mn) over 7 days.
Attachment of hASCs to TMPeTA-co-TMPTMP substrates was verified using
fluorescent microscopy imaging at 1, 4, and 7 days. Live/dead staining showed the
viability of the live cells by fluorescing green and dead cells by fluorescing red. The
adhesion of the hASCs on the polymer surface was analyzed by observing the spindle
shape cell morphology at day 1. Controls containing no cells were included as a means
of comparison. As shown in Figure 4-11, cells successfully attached to the surface of
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the TMPeTA(692) 2.8%-16.1% DEA polymer at day 1 post cell-seeding and remained
attached throughout the 7 day study. The live/dead stain images showed that cells
initially attached on TMPeTA(912)-co-TMPTMP samples (2.8-16.1% DEA) but at day 4
and 7 non-viable cells remained attached (Figure 4-11).
Cell proliferation studies were performed at different time points (day 1, 4, 7) for a
total of 7 days. The PicoGreen® results for all 8 groups have been shown in Figure 4-15.
For the 4 TMPeTA(692) samples, an increase in cell number was indicated from day 1
to 7 after seeding, similar to the positive control samples. In contrast, TMPeTA(912)
samples revealed a low number of cells initially adhered followed by a steady decrease
in attached cells from day 1 and 7. Analysis of DNA values showed that TMPeTA
polymers synthesized with the lower average molecular weight, 692, are more suitable
substrates for cellular proliferation. Live/dead staining results are in agreement with the
PicoGreen® results (Figure 4-14), which showed a significant drop in the number of cells
for TMPeTA(912) while showing a proliferation of cells for the TMPeTA(692) samples.
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16.1% Positive
Control

Figure 4-15. DNA content TMPeTA(692)-TMPTMP samples (2.8%, 5%, 10% and
16.1% DEA), and TMPeTA(912)-TMPTMP ( 2.8%, 5%, 10% and 16.1% DEA).
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4.9 Stem Cell Encapsulation Methods
4.9.1 Fabrication of Cell Encapsulation Within Polymers
The agarose gel was prepared by mixing 2.0 g agarose with 100 ml stromal
media followed by heating in the microwave for 30 seconds. HASC were cultured
according to Section 4.3.5 and dispersed in agarose/stromal medium immediately
before the agarose reached its gelation temperature of ~37 °C. The agarose gel was
sieved through a piece of metal mesh to create smaller gel pieces and to allow for better
distribution when mixed with the monomer precursor solution. The PEGDA(700),
TMPTMP and DEA were filtered with a 0.45 µm nylon filter to ensure complete
sterilization. The nucleophile-initiated PEGDA(700) polymer was prepared similar to
Section 4.3.1 except the foaming apparatus was used alike to PETA. The DEA was
added to the PEGDA(700) monomer first, mixed for 30 seconds, TMPTMP was added,
and the foam was expelled from the canister and mixed with cell laden agarose gel bits
before gelation of the polymer at ~8 minutes. The in-situ live cell polymerization reaction
was repeated 3 times to ensure reproducibility.
The agarose was replaced with alginate for the remaining encapsulation
experiments due to its homogenous uniform size compared to agarose. The alginate
solution was synthesized by dissolving sodium alginate powder into stromal media at a
2% concentration by stirring for 4 hours. The hASCs were mixed gently with the filtered
alginate solution. The alginate/cell mixture was added dropwise using a syringe into a
1% calcium chloride solution instantaneously forming a bead upon contact. A syringe
pump set at a rate of 1 mL/min was used to assist in the bead formation to ensure the
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encapsulation is finished in less than one hour. The alginate beads were washed 3x
with PBS.
For the alginate bead encapsulation experiments, the base-catalyzed PEGDA
polymer was prepared as mentioned in Section 4.3.1 and foamed like PETA in chapter
2 and 3. Once the precursor monomer/DEA stock solution and TMPTMP was mixed, it
was foamed and allowed to sit for 5 minutes to allow for the maximum reaction
temperature to be reached and for cooling to occur. The beads were then added and
gently stirred using a sterile spatula. For the positive control of each, the alginate beads
and agarose pieces weren’t encapsulated into the polymer but rather placed in a 6 well
plate with 500 µl of stromal media.
4.9.2 Temperature Measurement, Live/Dead Staining, and AlamarBlue®
The maximum temperature of the reaction before gelation was measured for
each of the PEGDA(700) samples(1, 2, 3.5, 5, 7.5, 9% DEA) for 7.5 and 10% PBS. A
thermocouple wire was placed in the PEGDA(700)/DEA/TMPTMP solution as soon as
the thiol was added and Logger Pro software from Vernier was used to measure the
temperature.
Live/Dead Staining was carried out on both the agarose and alginate
experiments according to Section 4.4.5. One hour prior to imaging, the agarose gel
pieces were removed from the PEGDA(700) nucleophile-initiated polymer, the stain was
added to the pieces, and the pieces were imaged. For the alginate bead experiments,
the beads were removed from the polymer (base-catalyzed PEGDA or TMPeTA) 1 hour
prior to imaging, the stain was added, and the beads were imaged.
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AlamarBlue® experiments were executed on the alginate beads that were
contained within the TMPeTA(692) 5 and 10% polymer. The beads were removed from
the polymer matrix after 3 days of incubation at 37 °C, and the fluorescence were read
on the plate reader.
4.10 Encapsulation Results
The PEGDA polymer synthesized by nucleophilic and base-catalyzed
mechanisms did not support cell attachment to the surface of the polymer as shown by
the cell morphology in both live/dead staining and SEM imaging. Therefore, the PEGDA
polymer was used as a transfer matrix to bind the cell encapsulated agarose or alginate
beads together. Although stem cell encapsulation for tissue engineering has been a
challenge, some research groups in recent years have been successful by using naturederived polysaccharides that form a hydrogel once dissolved in water.
To prevent heat shock and death to the encapsulated cells, the temperature of
the exothermic thiol-acrylate polymerization was measured. The temperature of the
PEGDA polymer nucleophile reaction with 0.5% DEA was measured and decreased
from 47 °C to 39 °C in ~5 minutes, leaving time for the addition of the agarose
encapsulated cells pieces before gelation. The 0.5% DEA is attractive for cell
encapsulation as it gives off less heat than the 2% DEA, and its gel time is slower at 8
min. The 0.5% DEA should give off more heat because there is higher conversion
(Figure 4-2) while the 2% DEA’s temperature may increase higher because the reaction
is faster. For the base-catalyzed PEGDA reaction using alginate beads, the temperature
was also tested for the different PEGDA polymers catalyzed by varying DEA (%). The
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reaction temperature increased with increasing catalyst concentration due to the rate
increasing which decreases the time needed for heat to dissipate.
The live/dead staining image (Figure 4-16) shows the viability of cells trapped in
agarose within the 0.5% DEA nucleophile-initiated PEGDA(700) polymer. Green dots
represent live cells, while the red dots represent dead cells. Existing green dots show
cells are alive after the process of encapsulating in the agarose gel and furthermore
mixing it into the pre-cursor solution. The cells survived the polymerization reaction as
shown in the live/dead assay.

Figure 4-16. Agarose live/dead image. The left shows live cells while the right image
shows dead cells
Due to the ability of alginate, another polysaccharide hydrogel, to form uniform
beads with calcium chloride, the agarose was no longer used in remaining
encapsulation experiments. Since the solution that the cells are in is not pure stromal
media but rather contains alginate dissolved in stromal media, the cells will begin to die
after one hour. The formation of the cell alginate capsules was done in less than one
hour to prevent unnecessary cell death. The 1 ml/minute produced alginate particles
that ranged in size from 2.4-3.0 mm.
Live/dead staining in conjunction with confocal microscopy at the 7 and 14-day
time mark was used to determine if cell survival would be observed and shown in Figure
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4-17. The difference between the 7 and 14-day results is the cell viability where more
red cells were observed at day 14 compared to day 7 images.

PEGDA(700)

Control

Week 1

Week 2

Figure 4-17. Live/dead staining of the PEGDA(700) base-catalyzed polymer compared
to the control
TMPeTA(692) 5 and 10% DEA was also tested as cell-laden alginate bead
carriers. The live/dead imaging (Figure 4-18) for both were relatively similar, therefore
AlamarBlue® was tested for the cell viability within the beads (Figure 4-19). The 5%
DEA had 80% relative metabolic activity while the 10% had almost 100%, which is
comparable to the positive control beads. The positive control was the alginate beads
that were not added to the precursor monomer solution before gelation.
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TMPeTA(692) DAY 3
5%DEA
10%DEA

Figure 4-18. Live/dead staining of hASC/alginate within 5 and 10% DEA TMPeTA(692)
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Figure 4-19. Relative Metabolic Activity of hASC alginate beads encapsulated in 5 and
10% DEA TMPeTA(692) polymer at day 3
4.11 Conclusion
The mechanism by which hASCs attach to polymeric substrates is a complicated
process involving many factors such as wettability, crosslinking density, and
degradability. The TMPTA and PEGDA(700) did not display any cell attachment which
may be due to a combination of wettability and crosslinking density. When comparing
TMPeTA(692) to TMPeTA(912), the TMPeTA(692) polymer displayed better cell
attachment/proliferation versus the TMPeTA(912) samples due to its higher crosslinking
density, moderate hydrophilicity, and greater stability in physiological solution. The in
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situ amine catalyst was also a contributing factor, as seen in the 16.1% DEA
TMPeTA(692) sample which exhibited mass loss comparable to 912 samples, but it is
hypothesized that the higher charge density of the 692 sample promotes cell
attachment/proliferation. The 10% DEA TMPeTA(692) is the best candidate overall for
tissue regeneration due to its lack of degradation and sustained cell
attachment/proliferation over 7 days. An alternative for materials such as PEGDA that
do not support cell attachment is encapsulation. The PEGDA(700) displayed more live
cells than dead cells even after 14 days.
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Chapter 5. Overall Conclusion
The PETA-co-TMPTMP polymer was characterized extensively, not only in
reference to material properties but also its biocompatibility properties. The 16.1%
PETA-co-TMPTMP gelled in ~20 minutes which allowed for preparation and foaming
time. FTIR analysis displayed that the acrylate conversion reaches close to 100% in
less than 24 hours. The compressive strength of the solid was comparable to the
strength of cancellous bone. Adding hydroxyapatite presented an inorganic phase to the
polymer material and increased mechanical properties. It did however reduce pore size
of the foamed composite due its increased viscosity. Gas foaming using nitrous oxide
as the porogen produced the porosity of the scaffolds. The extractive cytotoxicity of PCL
(foam) displayed a drop in relative cell viability while all the PETA (solid/foam) displayed
comparable cell viability to the live control. Cell seeding on the PCL and PETA + HA
displayed reduced metabolic activity that is often associated with HA, which suggests
that the cells were differentiating and taking on a different metabolic activity. The PETA
foams prepared in stromal media versus in situ did not show a difference in porosity or
mechanical strength. Moreover, hASCs cultured on foamed PETA:HA (80:20) scaffolds
resulted in the greatest mineralization, increased alkaline phosphatase (ALP)
expression, and the highest osteocalcin (OCN) expression after 21 days.
Adding an antimicrobial portion to the polymer by soaking the PETA-co-TMPTMP
(20%excess thiol) in a SNP containing solvent, known as the coating method, aided in
the transport and release of SNPs. This antimicrobial element led to the PETA scaffold
having a defense mechanism against common hospital acquired infections, E. coli and
Staph. Aureus.
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For the cell adhesion study, PEGDA(700) synthesized via nucleophile-initiated
and base-catalyzed mechanisms did not yield promising results for cell attachment.
Despite studies showing thiols promoting cell attachment, excess thiol formulations
exhibited negative results the cytotoxicity studies at 7 days. The TMPeTA(692) 10%
DEA was the most favorable material for future projects due it’s lack of degradation and
support of cell proliferation/adhesion.
Future applications for base-catalyzed Michael addition reactions are vast due to
their robust nature and ease of synthesis at room temperature. Future work for these
thiol-acrylate polymers could involve the incorporation of RGD, a cell adhesive
tripeptide, by performing a Michael addition between the acrylate and the amine group
found on the RGD molecule. This would directly incorporate the peptide into the
polymerization reaction resulting in an even greater increase in cell
attachment/proliferation on these thiol-acrylate materials.
Additionally, to further the understanding between cell and surface interactions,
focal adhesion of the samples could be performed to prove the relationship between the
surface modulus and cell attachment. Other variables besides the ones studied in the
4th chapter of the polymer could be altered such as using a tertiary amine, which would
not impart a positive charge or add onto the acrylate. This would give more insight to
the overall surface charge of the polymer and how it affects the cell adhesion.
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